Cinemark Usa 10-K 4 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 01, 2019	Jun. 30, 2018
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	FY
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	885,975
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Public Float			$ 0
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2018		Dec. 31, 2017
Current assets
Cash and cash equivalents		$ 426,216		$ 522,415
Inventories		19,319		17,507
Accounts receivable		95,076		89,248
Current income tax receivable		3,288		11,730
Prepaid expenses and other		15,114		16,536
Accounts receivable from parent		19,530		14,581
Total current assets		578,543		672,017
Theatre properties and equipment
Land		103,739		104,207
Buildings		522,355		490,394
Property under capital lease		387,480		430,764
Theatre furniture and equipment		1,239,122		1,199,702
Leasehold interests and improvements		1,151,454		1,103,522
Total		3,404,150		3,328,589
Less: accumulated depreciation and amortization		1,571,017		1,500,535
Theatre properties and equipment, net		1,833,133		1,828,054
Other assets
Goodwill	[1]	1,276,324		1,284,079
Intangible assets - net		330,910		336,761
Investments in and advances to affiliates		156,766		120,045
Long-term deferred tax asset		9,028		4,067
Deferred charges and other assets - net		41,055		39,767
Total other assets		2,089,675		1,985,269
Total assets		4,501,351		4,485,340
Current liabilities
Current portion of long-term debt		7,984		7,099
Current portion of capital lease obligations		27,065	[2]	25,511
Current income tax payable		12,179		5,509
Current liability for uncertain tax positions		573		11,873
Accounts payable		104,615		109,984
Accrued film rentals		95,754		106,738
Accrued payroll		46,500		50,349
Accrued property taxes		31,154		31,353
Accrued other current liabilities		148,229		119,870
Total current liabilities		474,053		468,286
Long-term liabilities
Long-term debt, less current portion		1,772,627		1,780,381
Capital lease obligations, less current portion		232,467	[2]	251,151
Long-term deferred tax liability		155,626		121,787
Long-term liability for uncertain tax positions		13,380		8,358
Deferred lease expenses		39,235		40,929
Other long-term liabilities		49,431		41,247
Total long-term liabilities		2,550,115		2,595,559
Commitments and contingencies (see Note 16)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)		(24,233)
Additional paid-in-capital		1,277,921		1,264,505
Retained earnings		480,580		373,069
Accumulated other comprehensive loss		(319,007)		(253,282)
Total Cinemark USA, Inc.'s stockholder's equity		1,464,804		1,409,602
Noncontrolling interests		12,379		11,893
Total equity		1,477,183		1,421,495
Total liabilities and equity		4,501,351		4,485,340
NCM
Other assets
Investment in NCM		275,592		200,550
Long-term liabilities
Deferred revenue - NCM		287,349	[3]	351,706
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0		0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		49,543
Total equity		$ 49,543		$ 49,543
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.
[3]	Includes the cumulative effect of accounting change of $53,605 recorded on January 1, 2018 and the full year impact of the change in amortization method of $4,104 during the year ended December 31, 2018.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Treasury stock, shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648
Common stock, par value	$ 0	$ 0

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues
Total revenues		$ 3,221,735	$ 2,991,547	$ 2,918,765
Cost of operations
Film rentals and advertising		999,755	966,510	962,655
Concession supplies		180,974	166,320	154,469
Salaries and wages		383,860	354,510	325,765
Facility lease expense		323,316	328,197	321,294
Utilities and other		448,070	355,041	355,926
General and administrative expenses		162,640	150,911	140,637
Depreciation and amortization		261,162	237,513	209,071
Impairment of long-lived assets		32,372	15,084	2,836
Loss on disposal of assets and other		38,702	22,812	20,459
Total cost of operations		2,830,851	2,596,898	2,493,112
Operating income		390,884	394,649	425,653
Other income (expense)
Interest expense	[1]	(109,994)	(105,918)	(108,313)
Loss on debt amendments and refinancing		(1,484)	(521)	(13,445)
Interest income		10,592	6,243	6,396
Foreign currency exchange gain (loss)		(11,660)	893	6,455
Equity in income of affiliates		39,242	35,985	31,962
Total other expense		(77,639)	(46,911)	(62,289)
Income before income taxes		313,245	347,738	363,364
Income taxes		96,032	80,256	104,851
Net income		217,213	267,482	258,513
Less: Net income attributable to noncontrolling interests		1,478	1,839	1,736
Net income attributable to Cinemark USA, Inc.		215,735	265,643	256,777
Admissions
Revenues
Total revenues		1,834,173	1,794,982	1,789,137
Concession
Revenues
Total revenues		1,108,793	1,038,788	990,103
Other
Revenues
Total revenues		278,769	157,777	139,525
NCM
Other income (expense)
Distributions from NCM		15,389	$ 16,407	$ 14,656
Interest expense - NCM		$ (19,724)
[1]	Includes amortization of debt issue costs.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 217,213	$ 267,482	$ 258,513
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $138, $0 and $1,243, net of settlements	(3,851)	0	234
Other comprehensive income (loss) in equity method investments	(139)	248	89
Foreign currency translation adjustments	(62,253)	(4,966)	26,394
Total other comprehensive income (loss), net of tax	(66,243)	(4,718)	26,717
Total comprehensive income, net of tax	150,970	262,764	285,230
Comprehensive income attributable to noncontrolling interests	(1,478)	(1,839)	(1,769)
Comprehensive income attributable to Cinemark USA, Inc.	$ 149,492	$ 260,925	$ 283,461

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement Of Income And Comprehensive Income [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,243	$ 0	$ 138

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Treasury Stock	Additional Paid-in- Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Noncontrolling Interests
Balance at Dec. 31, 2015	$ 1,113,251		$ 49,543	$ (24,233)	$ 1,238,473	$ 110,049	$ (271,686)	$ 1,102,146	$ 11,105
Balance (in shares) at Dec. 31, 2015		2	240	(57)
Share based awards compensation expense	12,413				12,413			12,413
Tax benefit (expense) related to share based award vestings	1,856				1,856			1,856
Dividends paid to parent	(124,900)					(124,900)		(124,900)
Dividends paid to noncontrolling interests	(1,309)								(1,309)
Buyout of noncontrolling interests' share of Chilean subsidiary	(450)				(27)			(27)	(423)
Gain realized on available-for-sale securities, net of taxes	(2,011)						(2,011)	(2,011)
Net income	258,513					256,777		256,777	1,736
Other comprehensive income (loss)	26,717						26,684	26,684	33
Balance at Dec. 31, 2016	1,284,080		$ 49,543	$ (24,233)	1,252,715	241,926	(247,013)	1,272,938	11,142
Balance (in shares) at Dec. 31, 2016		2	240	(57)
Share based awards compensation expense	11,825				11,825			11,825
Tax benefit (expense) related to share based award vestings	(35)				(35)			(35)
Dividends paid to parent	(134,500)					(134,500)		(134,500)
Dividends paid to noncontrolling interests	(1,088)								(1,088)
Net income	267,482					265,643		265,643	1,839
Reclassification of cumulative translation adjustments	(1,551)						(1,551)	(1,551)
Other comprehensive income (loss)	(4,718)						(4,718)	(4,718)
Balance at Dec. 31, 2017	1,421,495		$ 49,543	$ (24,233)	1,264,505	373,069	(253,282)	1,409,602	11,893
Balance (in shares) at Dec. 31, 2017		2	240	(57)
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)	40,526					40,526		40,526
Share based awards compensation expense	13,416				13,416			13,416
Dividends paid to parent	(148,750)					(148,750)		(148,750)
Dividends paid to noncontrolling interests	(992)								(992)
Net income	217,213					215,735		215,735	1,478
Reclassification of cumulative translation adjustments	518						518	518
Other comprehensive income (loss)	(66,243)						(66,243)	(66,243)
Balance at Dec. 31, 2018	$ 1,477,183		$ 49,543	$ (24,233)	$ 1,277,921	$ 480,580	$ (319,007)	$ 1,464,804	$ 12,379
Balance (in shares) at Dec. 31, 2018		2	240	(57)

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2016
Statement Of Stockholders Equity [Abstract]
Gain realized on available-for-sale securities, taxes		$ 1,180
Cumulative effect of change in accounting principle, taxes	$ 13,079

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities
Net income		$ 217,213	$ 267,482	$ 258,513
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		257,826	235,093	207,091
Amortization of intangible and other assets and favorable/unfavorable leases		3,336	2,420	1,980
Amortization of long-term prepaid rents		2,382	2,274	1,826
Amortization of debt issue costs		5,561	6,197	5,492
Amortization of deferred revenues, deferred lease incentives and other		(21,706)	(16,211)	(16,731)
Impairment of long-lived assets		32,372	15,084	2,836
Share based awards compensation expense		13,416	11,825	12,413
Loss on disposal of assets and other		38,702	22,812	20,459
Loss on debt amendments and refinancing		1,484	521	13,445
Deferred lease expenses		(1,320)	(1,268)	(990)
Reclassification of cumulative translation adjustments		518	(1,551)
Equity in income of affiliates		(39,242)	(35,985)	(31,962)
Deferred income tax expenses		23,187	(15,015)	(5,467)
Distributions from equity investees	[1]	30,143	25,973	21,916
Changes in assets and liabilities and other
Inventories		(1,813)	(541)	(1,007)
Accounts receivable		(6,620)	(14,753)	(2,781)
Income tax receivable		8,442	(4,363)	15,510
Prepaid expenses and other		1,422	(782)	(2,260)
Deferred charges and other assets - net		(6,303)	(4,956)	(1,619)
Accounts payable and accrued expenses		(11,272)	23,355	(30,250)
Income tax payable		6,670	438	(2,261)
Liabilities for uncertain tax positions		(10,066)	2,041	1,182
Other long-term liabilities		11,967	8,294	(5,076)
Net cash provided by operating activities		556,299	528,384	462,259
Investing activities
Additions to theatre properties and equipment and other		(346,073)	(380,862)	(326,908)
Proceeds from sale of theatre properties and equipment and other		3,920	15,098	3,570
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(11,289)	(40,997)	(15,300)
Acquisition of screen advertising business				(1,450)
Proceeds from sale of marketable securities				13,451
Investment in joint ventures and other, net		(19,535)	(3,715)	(1,132)
Net cash used for investing activities		(451,370)	(410,476)	(327,769)
Financing activities
Dividends paid to parent		(148,750)	(134,500)	(124,900)
Payroll taxes paid as a result of restricted stock withholdings		(2,905)	(2,943)	(6,834)
Proceeds from issuance of Senior Notes, net of discount				222,750
Retirement of Senior Subordinated Notes				(200,000)
Repayments of long-term debt		(7,984)	(5,671)	(16,605)
Payment of debt issue costs		(5,218)	(1,146)	(7,217)
Fees paid related to debt amendments		(704)	(521)	(11,076)
Payments on capital leases		(25,353)	(21,725)	(19,343)
Proceeds from financing lease			10,200
Purchases of non-controlling interests				(450)
Other		(992)	(1,123)	554
Net cash used for financing activities		(191,906)	(157,429)	(163,121)
Effect of exchange rate changes on cash and cash equivalents		(9,222)	798	1,266
Increase (decrease) in cash and cash equivalents		(96,199)	(38,723)	(27,365)
Cash and cash equivalents:
Beginning of period		522,415	561,138	588,503
End of period		426,216	$ 522,415	$ 561,138
NCM
Investing activities
Acquisition of NCM common units		$ (78,393)
[1]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay. Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds, certificates of deposit or other similar funds. Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, receivables related to discounted tickets and gift cards sold third party to retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables. Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market. Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its impairment assessment. Long-lived assets are evaluated for impairment on a theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2016, 2017 and 2018. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 7 for further discussion. Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill. A quantitative analysis requires the Company to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017 and 2018. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017 and 2018. A qualitative assessment includes consideration of historical and expected future industry performance, estimated future performance of the Company, current industry trading multiples and other economic factors, and a review of current carrying values to estimated fair values as determined during our most recent quantitative assessment. We performed a qualitative assessment for all reporting units for the year ended December 31, 2016. We performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, we performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. We did not record any goodwill impairment charges as a result of the assessments performed during the years ended December 31, 2016, 2017 and 2018. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment. During the year ended December 31, 2016, the Company performed a quantitative tradename impairment assessment for our tradename in Ecuador and performed a qualitative tradename impairment analysis for all other tradename intangible assets. During the year ended December 31, 2017, the Company performed quantitative tradename impairment evaluations for all of its tradename assets. During the year ended December 31, 2018, the Company performed a qualitative tradename impairment analysis for all of its tradename assets. As a result of the analysis performed during each year, no impairment charges were recorded related to tradename intangible assets for the years ended December 31, 2016, 2017 and 2018. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately two to eight years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is two years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately one to eighteen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eight years. Deferred Charges and Other Assets — Deferred charges and other assets consist of long-term prepaid rents, construction and other deposits, equipment to be placed in service, and other assets of a long-term nature. Long-term prepaid rents represent prepayments of rent on operating leases, which are recognized as facility lease expense over the period for which the rent was paid in advance as outlined in the lease agreements. The remaining amortization periods generally range from one to seventeen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements. Lease Accounting — The Company evaluates each lease for classification as either a capital lease or an operating lease. The Company records the lease as a capital lease at its inception if 1) the present value of future minimum lease payments exceeds 90% of the leased property’s estimated fair value; 2) the lease term exceeds 75% of the property’s estimated useful life; 3) the lease contains a bargain purchase option; or 4) ownership transfers to the Company at the end of the lease. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent expense impact of an operating lease upon inception of the lease. For some newly built theatres, the landlord is responsible for constructing the theatre using guidelines and specifications agreed to by the Company and assumes substantially all of the risks of construction. For other theatres, the Company is responsible for managing construction of the theatre and the landlord contributes an agreed upon amount toward the costs of construction. If the Company concludes that it has substantially all of the construction period risks, it considers itself the owner of the property during the construction period. At the end of the construction period, the Company determines if the transaction qualifies for sale-leaseback accounting treatment in regards to lease classification. If the Company receives a lease incentive payment from a landlord, the Company records the proceeds as a deferred lease incentive liability and amortizes the liability as a reduction in rent expense over the initial term of the lease if a new theatre, or over the remaining lease term if an existing theatre. See Note 2 for discussion of the expected impact of new lease accounting pronouncements. Deferred Revenues — Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the advances are earned, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as such revenues are earned in accordance with the terms of the contracts. In addition, the Company records deferred revenues for sales of gift cards and discounted ticket vouchers, as well as for proceeds received from its monthly subscription program, annual membership fees for certain of its loyalty programs and for points issued to customers under other loyalty programs. See Note 3 for further discussion of revenue recognition and Note 4 for discussion of deferred revenue – NCM. Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2016, 2017 and 2018, general liability claims were capped at $100, $250 and $250, respectively, per occurrence with aggregate annual caps of approximately $3,350, $3,900 and $4,750, respectively. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. In the U.S., the Company was fully insured for workers compensation claims during the year ended December 31, 2016. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000 for the years ended December 31, 2017 and 2018. The Company was also self-insured for domestic medical claims up to $150, $250 and $250 per occurrence for the years ended December 31, 2016, 2017 and 2018, respectively. As of December 31, 2017 and 2018, the Company’s insurance reserves were $8,252 and $10,827, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets Revenue and Expense Recognition — See Note 3 for discussion of revenue recognition. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final settlement rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at the time of settlement. Loyalty Programs – The Company launched its domestic app-based loyalty program, Connections, in February 2016. Customers earn points for various transactions as tracked within the app. Points may be redeemed for movie tickets, concessions items, concession discounts and experiential rewards, each of which are offered for limited periods of time and at varying times during the year. For the years ended December 31, 2016 and 2017, the Company applied the incremental cost approach to accounting for the rewards earned, as it determined that the values of the rewards offered to the customer are insignificant to the original transactions required to earn such rewards. The Company also has loyalty programs in certain of its international markets, which generally consist of the customer paying a membership fee in exchange for discounts during the membership period. Effective January 1, 2018, the Company adopted ASC Topic 606 and now accounts for its points-based loyalty programs by deferring a portion of the revenue associated with the transaction that earned such points. See Note 3 for discussion of revenue recognition as it relates to the Company’s loyalty programs. Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 13 for discussion of the Company’s share based awards and related compensation expense. Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. Segments — For the years ended December 31, 2016, 2017 and 2018, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 17. Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 11 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2016, 2017 and 2018. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency. Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 10 for a discussion of our fair value measurements for the year ended December 31, 2018. Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

New Accounting Pronouncements

New Accounting Pronouncements	12 Months Ended
	Dec. 31, 2018
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	2. NEW ACCOUNTING PRONOUNCEMENTS Impact of New Revenue Recognition Standard In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers Impact of New Lease Accounting Standard In February 2016, the FASB issued ASU 2016-02, Leases The Company adopted ASC Topic 842 effective January 1, 2019. The Company is finalizing its evaluation of the impact of ASC Topic 842 on its consolidated financial statements, and expects the most significant impacts to be as follows: 1. The Company will recognize liabilities representing the present value of the remaining future minimum lease payments for all of its operating leases as of January 1, 2019. The Company estimates these liabilities will be between $1,400,000 and $1,700,000. 2. The Company will recognize right of use assets for all of its operating leases equal to the liabilities calculated in (1) above, adjusted for the balances of long-term prepaid rent, favorable lease intangible assets, deferred lease expense, unfavorable lease liabilities and deferred lease incentive liabilities as of January 1, 2019. 3. The Company has theatre leases for which it was involved in construction that failed sale-leaseback accounting at the end of the construction period. These leases, which were accounted for as capital leases, will be derecognized upon adoption of ASC Topic 842 and evaluated to determine classification upon adoption. Some of these leases will be classified as operating leases upon adoption and, beginning in 2019, lease payments for these leases will be recorded as facility lease expense on the consolidated income statement. Previously, as capital leases, lease payments were classified as interest expense and reductions of the capital lease obligations. 4. For the capital leases derecognized as discussed in (3) above, the Company will write-off of the net book value of the capital lease asset and capital lease liability, with the difference between those amounts resulting in an adjustment to beginning retained earnings as of January 1, 2019. Other Accounting Pronouncements In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope Modification Accounting In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement U.S. Tax Reform On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries, and (4) created new taxes on certain foreign-sourced earnings. As of December 31, 2018, the amounts recorded for the Tax Act are final for the 2017 transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. See further discussion at Note 15.

Revenue Recognition

Revenue Recognition	12 Months Ended
	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Revenue Recognition	3. REVENUE RECOGNITION Revenue Recognition Policy The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when sales are made at the registers. Other revenues primarily consist of screen advertising and transactional fees. Screen advertising revenues are recognized over the period that the related advertising is delivered on-screen or in-theatre. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as current liabilities. Revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as current liabilities and records admissions revenues as the credits are redeemed for movie tickets. The Company also has loyalty programs in many of its locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as liabilities based on the number of reward points issued to customers and recognizes revenues when the customer redeems such points. Screen advertising revenues are generally recognized over the period that the related advertising is delivered on-screen or in-theatre. Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts. See additional revenue recognition policy considerations, updated for the adoption of ASC Topic 606, below. Adoption of ASC Topic 606 The Company adopted ASC 606, Revenue from Contracts with Customers, Changes to the way in which the Company recognizes revenue resulted in the following impacts to the consolidated statements of income: a) Recording of incremental other revenue and interest expense related to the significant financing component of the Company’s Exhibitor Services Agreement (“ESA”) with NCM, LLC (“NCM”). See further discussion below, including the estimated interest rates assumed in determining the amount of interest expense. b) Deferral of a portion of admissions and concession revenues for transactions that include the issuance of loyalty points to customers. To determine the amount of revenues to defer upon issuance of points to customers under its points-based loyalty programs, the Company estimated the values of the rewards expected to be redeemed by its customers for those points. The estimates are based on the rewards that have historically been offered under the loyalty programs, which the Company believes is representative of the rewards to be offered in the future. c) Increase in other revenues and an increase in utilities and other expenses due to the presentation of transactional fees on a gross versus net basis. d) Increase in other revenues due to the change in amortization methodology for deferred revenue – NCM that is now amortized on a straight-line basis and effective for the entire term of the ESA. The deferred revenue – NCM is related to the Company’s ESA and Common Unit Adjustment agreement with NCM, under which the Company’s performance obligation is to provide NCM with exclusive access to its domestic theatres for purposes of in-theatre advertising over the term of the ESA. Such exclusivity, and therefore the satisfaction of the Company’s performance obligation, is provided to NCM evenly over time. As a result of the change in amortization method, the Company recorded a cumulative effect of accounting change adjustment of $40,526, net of taxes, in retained earnings on January 1, 2018 (see also Note 6). The significant changes discussed above had the following impact on the Company’s statements of income and cash flows for the year ended December 31, 2018: Without Adoption of ASC 606 Impact of Adoption of ASC 606 As Reported Statement of income: Admissions revenues $ 1,839,723 $ (5,550 ) $ 1,834,173 Concession revenues $ 1,110,703 $ (1,910 ) $ 1,108,793 Other revenues $ 161,743 $ 117,026 $ 278,769 Utilities and other expense $ 354,740 $ 93,330 $ 448,070 Interest expense - NCM $ — $ 19,724 $ 19,724 Statement of cash flows: Amortization of deferred revenues, deferred lease incentives and other $ (17,602 ) $ (4,104 ) $ (21,706 ) Changes in other assets and liabilities - Other long-term liabilities $ 4,375 $ 7,592 $ 11,967 The impact of adoption of ASC 606 on the Company’s balance sheet as of December 31, 2018 was as follows: Without Adoption of ASC 606 Impact of Adoption of ASC 606 As Reported Balance sheet line items: Deferred revenue - NCM (1) $ 345,058 $ (57,709 ) $ 287,349 Long-term deferred tax liability $ 142,547 $ 13,079 $ 155,626 Other long-term liabilities $ 41,839 $ 7,592 $ 49,431 Retained earnings $ 440,054 $ 40,526 $ 480,580 (1) Includes the cumulative effect of accounting change of $53,605 recorded on January 1, 2018 and the full year impact of the change in amortization method of $4,104 during the year ended December 31, 2018. The Company applied the practical expedient to exclude sales and other similar taxes collected from customers from its transaction price for purposes of recording revenues. As such, revenues are presented net of such taxes. Disaggregation of Revenue The following table presents revenues for the year ended December 31, 2018, disaggregated based on major type of good or service and by reportable operating segment. Twelve Months Ended December 31, 2018 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 1,461,151 $ 373,022 $ 1,834,173 Concession revenues 892,391 216,402 1,108,793 Screen advertising and promotional revenues 78,591 61,269 139,860 Other revenues 106,824 32,085 138,909 Total revenues $ 2,538,957 $ 682,778 $ 3,221,735 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations. The following table presents revenues for the year ended December 31, 2018, disaggregated based on timing of revenue recognition (as discussed above). Twelve Months Ended December 31, 2018 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,453,313 $ 608,347 $ 3,061,660 Goods and services transferred over time 85,644 74,431 160,075 Total $ 2,538,957 $ 682,778 $ 3,221,735 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations. Deferred Revenues The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2018. Deferred Revenues Deferred Revenue - NCM Other Deferred Revenues (1) Total Balance at January 1, 2018 $ 351,706 $ 86,498 $ 438,204 Impact of adoption of ASC Topic 606 (53,605 ) — (53,605 ) Amounts recognized as accounts receivable — 6,921 6,921 Cash received from customers in advance — 156,237 156,237 Common units received from NCM (see Note 6) 5,012 — 5,012 Revenue recognized during period (15,764 ) (141,176 ) (156,940 ) Foreign currency translation adjustments — (2,405 ) (2,405 ) Balance at December 31, 2018 $ 287,349 $ 106,075 $ 393,424 (1) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2018 and when the Company expects to recognize this revenue. Twelve Months Ended December 31, Remaining Performance Obligations 2019 2020 2021 2022 2023 Thereafter Total Deferred revenue - NCM $ 15,831 $ 15,831 $ 15,831 $ 15,831 $ 15,831 $ 208,194 $ 287,349 Deferred revenue - other 89,523 16,146 207 199 — — 106,075 Total $ 105,354 $ 31,977 $ 16,038 $ 16,030 $ 15,831 $ 208,194 $ 393,424 Accounts receivable as of December 31, 2018 included approximately $48,117 of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the year ended December 31, 2018. Significant Financing Component As discussed further in Note 4, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2037. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. See Note 4 for additional information regarding the common unit adjustment and related accounting. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. As a result of the significant financing component on deferred revenue - NCM, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $19,724 during the year ended December 31, 2018. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 5.5% to 8.0%.

Investment in National CineMedi

Investment in National CineMedia LLC	12 Months Ended
	Dec. 31, 2018
NCM
Investment in National CineMedia LLC	4. INVESTMENT IN NATIONAL CINEMEDIA LLC The Company has an investment in National CineMedia, LLC (“NCM”). NCM operates a digital in-theatre network in the U.S. for providing cinema advertising and non-film events. Upon joining NCM, the Company entered into an Exhibitor Services Agreement (“ESA”) with NCM, pursuant to which NCM provides advertising, promotion and event services to our theatres. On February 13, 2007, The ESA modification reflected a shift from circuit share expense under the prior ESA, which obligated NCM to pay the Company a percentage of revenue, to a monthly theatre access fee, which significantly reduced the contractual amounts paid to us by NCM. The Company recorded the proceeds related to the ESA modification as deferred revenue. As a result of the application of a portion of the proceeds it received from the NCMI initial public offering, the Company had a negative basis in its original membership units in NCM, which is referred to herein as the Company’s Tranche 1 Investment. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM's net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor's basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Common Unit Adjustments Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC and Regal, whom we refer to collectively as the Founding Members, adjustments are made annually to the common membership units primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, we follow the guidance in FASB ASC 323-10-35-29 (formerly EITF 02-18, “Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss Recognition” Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2016, 2017 and 2018: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2016 annual common unit adjustment 3/31/2016 753,598 $ 11,111 2017 annual common unit adjustment 3/31/2017 1,487,218 $ 18,363 2018 annual common unit adjustment 3/29/2018 908,042 $ 5,012 Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective NCMI shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. The Company records the additional common units it receives as part of its Tranche 2 Investment at estimated fair value with a corresponding adjustment to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. Acquisition of Common Units On July 5, 2018, the Company acquired 10,738,740 common units of NCM from AMC for $78,393 in cash, or approximately $7.30 per common unit. As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%. The amount paid for the additional common units was recorded as an increase in the Company’s Tranche 2 investment in NCM. As of December 31, 2018, the Company owned a total of 39,518,644 common units of NCM, which represented an interest of approximately 25%. The estimated fair value of the Company’s investment in NCM was approximately $256,081 based on NCMI’s stock price as of December 31, 2018 of $6.48 per share (Level 1 input as defined in FASB ASC Topic 820), which was less than the Company’s carrying value of $275,592. The Company does not believe that the decline in NCMI’s stock price is other than temporary and therefore, no impairment of the Company’s investment in NCM was recorded during the year ended December 31, 2018. The market value of NCMI’s stock price may continue to vary due to the performance of the business, industry trends, general and economic conditions and other factors. Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 3 for discussion of impact of new revenue recognition accounting pronouncements. Investment in NCM Deferred Revenue Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (3) Cash Received (Paid) Balance as of January 1, 2016 $ 183,755 $ (342,134 ) Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the twelve months ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of deferred revenue — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 Impact of adoption of ASC Topic 606 (2) — 53,605 $ — $ — $ — $ — $ — Receipt of common units due to annual common unit adjustment 5,012 (5,012 ) — — — — — Purchase of additional common units 78,393 — — — — — — Revenues earned under ESA (1)(3) — — — — (31,867 ) 19,724 12,143 Receipt of excess cash distributions (19,786 ) — (13,231 ) — — — 33,017 Receipt under tax receivable agreement (2,419 ) — (2,158 ) — — — 4,577 Equity in earnings 13,842 — — (13,842 ) — — — Amortization of deferred revenue (2) — 15,764 — — (15,764 ) — — Balance as of and for the twelve months ended December 31, 2018 $ 275,592 $ (287,349 ) $ (15,389 ) $ (13,842 ) $ (47,631 ) $ 19,724 $ 49,737 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $10,523, $11,110 and $11,965 for the years ended December 31, 2016, 2017 and 2018, respectively. (2) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings. See Note 3 for further discussion of the impact of the adoption of ASC Topic 606. (3) Reflects the impact of significant financing component related to amounts received in advance under the ESA and CUA agreement. See Note 3. The Company made payments to NCM of approximately $49, $102 and $74 during the years ended December 31, 2016, 2017 and 2018, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. The tables below present summary financial information for NCM for the periods indicated: Year Ended Year Ended Year Ended December 29, 2016 December 28, 2017 December 27, 2018 Revenues $ 447,600 $ 426,100 $ 441,400 Operating income $ 173,000 $ 153,900 $ 154,300 Net income $ 109,300 $ 101,900 $ 98,400 As of As of December 28, 2017 December 27, 2018 Current assets $ 174,400 $ 172,700 Noncurrent assets $ 758,300 $ 726,800 Current liabilities $ 123,300 $ 115,200 Noncurrent liabilities $ 925,400 $ 924,900 Members' deficit $ (116,000 ) $ (140,600 )

Other Investments

Other Investments	12 Months Ended
	Dec. 31, 2018
Financial Support For Nonconsolidated Legal Entity [Abstract]
Other Investments	5. OTHER INVESTMENTS Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP RealD AC LLC DCDC FE Concepts Other Total Balance at January 1, 2016 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ — $ 663 $ 94,973 Cash contributions 717 — — — — 415 1,132 Equity in income 21,434 — 311 870 — — 22,615 Equity in comprehensive income 89 — — — — — 89 Sale of investment (1) — (12,900 ) — — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — — (7,698 ) Other (2) — — — (584 ) — 690 106 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ — $ 1,768 $ 98,317 Cash contributions 1,112 — — — 104 2,499 3,715 Equity in income 22,900 — 2,336 1,199 — — 26,435 Equity in comprehensive income 248 — — — — — 248 Cash distributions received (5,864 ) — (2,400 ) (351 ) — — (8,615 ) Other — — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ — $ 5,916 $ 3,598 $ 104 $ 4,212 $ 120,045 Cash contributions 2,076 — — — 20,000 — 22,076 Equity in income (loss) 22,899 — 1,270 1,313 (82 ) — 25,400 Equity in comprehensive loss (139 ) — — — — — (139 ) Cash distributions received (5,799 ) — (1,920 ) (219 ) — — (7,938 ) Other (2) — — — (2,437 ) (104 ) (137 ) (2,678 ) Balance at December 31, 2018 $ 125,252 $ — $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 (1) RealD, Inc (2) Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of December 31, 2018, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP as of and for the years ended December 31, 2016, 2017 and 2018: Year ended December 31, 2016 2017 2018 Revenues $ 178,836 $ 177,382 $ 172,534 Operating income $ 107,919 $ 106,687 $ 102,236 Net income $ 89,152 $ 93,103 $ 94,757 As of December 31, 2017 December 31, 2018 Current assets $ 56,296 $ 57,907 Noncurrent assets $ 772,438 $ 684,545 Current liabilities $ 59,153 $ 67,408 Noncurrent liabilities $ 296,889 $ 125,596 Members' equity $ 472,692 $ 549,448 The digital projection systems are being leased from Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company, under an operating lease with an initial term of twelve years that contains ten one-year fair value renewal options. The equipment lease agreement also contains a fair value purchase option. Under the equipment lease agreement, the Company pays annual rent of one thousand dollars per digital projection system. The Company may also be subject to various types of other rent if such digital projection systems do not meet minimum performance requirements as outlined in the agreements. Certain of the other rent payments are subject to either a monthly or an annual maximum. As of December 31, 2018, the Company had 3,837 digital projection systems being leased under the master equipment lease agreement with Kasima. The Company had the following transactions with DCIP during the years ended December 31, 2016, 2017 and 2018: Year Ended December 31, 2016 2017 2018 Equipment lease payments $ 5,217 $ 5,743 $ 4,862 Warranty reimbursements from DCIP $ (6,091 ) $ (8,511 ) $ (10,800 ) Management services fees $ 825 $ 823 $ 730 RealD, Inc. (“RealD”) The Company licenses 3-D systems from RealD. Under its license agreement with RealD, the Company earned options to purchase shares of RealD common stock as it installed a certain number of 3-D systems as outlined in the license agreement. During 2010 and 2011, the Company vested in a total of 1,222,780 RealD options. Upon vesting in these options, the Company recorded an investment in RealD and a deferred lease incentive liability using the estimated fair value of the RealD options at the time of vesting. During March 2011, the Company exercised all of its options to purchase shares of common stock in RealD for $0.00667 per share. The Company owned 1,222,780 shares of RealD and accounted for its investment in RealD as a marketable security, specifically an available-for-sale security, in accordance with ASC Topic 320-10-35-1, therefore unrealized holding gains and losses were reported as a component of accumulated other comprehensive loss until realized. On March 22, 2016, an affiliate of Rizvi Traverse Management, LLC acquired RealD for $11.00 per share. As a result of the transaction, the Company sold its shares for approximately $13,451 and recognized a gain of $3,742, which included the recognition of a cumulative unrealized holding gain of $3,191 previously recorded in accumulated other comprehensive loss. The gain is reflected within loss on disposal of assets and other on the consolidated statement of income for the year ended December 31, 2016. The Company used the proceeds to make a pre-payment on its term loan in accordance with the terms of its senior secured credit facility. AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $10,871, $13,950 and $12,481 for the years ended December 31, 2016, 2017 and 2018, respectively, which are included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in AC under the equity method of accounting. AC was formed by the AC Founding Members and NCM. NCM contributed the assets associated with its Fathom Events division to AC. Each of the Founding Members contributed cash of approximately $268 and a six-year promissory note in the amount of $8,333 in exchange for 32% of Class A Units in AC. Each of the Founding Members’ Promissory Notes bear interest at 5% per annum and require annual principal and interest payments. The remaining outstanding balance of the note payable from the Company to NCM as of December 31, 2018 was $1,389. Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $939, $848 and $927 to DCDC during the years ended December 31, 2016, 2017 and 2018, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in DCDC under the equity method of accounting. FE Concepts, LLC During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS - NET	12 Months Ended
	Dec. 31, 2018
Goodwill And Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS - NET	6. GOODWILL AND OTHER INTANGIBLE ASSETS — NET The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 Acquisitions of theatres (2) 9,878 13,211 23,089 Foreign currency translation adjustments — (1,973 ) (1,973 ) Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 Acquisitions of theatres (3) — 7,204 7,204 Foreign currency translation adjustments — (14,959 ) (14,959 ) Balance at December 31, 2018 (1) $ 1,174,041 $ 102,283 $ 1,276,324 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) (3) Amount represents preliminary purchase price allocation for theatres acquired in Brazil. As of December 31, intangible assets-net, consisted of the following: Balance at Balance at January 1, December 31, 2017 Additions (1) Amortization Other (2) 2017 Intangible assets with finite lives: Gross carrying amount $ 99,796 $ 11,584 $ — $ (5,485 ) $ 105,895 Accumulated amortization (64,606 ) — (5,563 ) 1,300 (68,869 ) Total net intangible assets with finite lives $ 35,190 $ 11,584 $ (5,563 ) $ (4,185 ) $ 37,026 Intangible assets with indefinite lives: Tradename 299,709 — — 26 299,735 Total intangible assets — net $ 334,899 $ 11,584 $ (5,563 ) $ (4,159 ) $ 336,761 Balance at Balance at January 1, December 31, 2018 Additions (3) Amortization Other (2) 2018 Intangible assets with finite lives: Gross carrying amount $ 105,895 $ 1,203 $ — $ (1,842 ) $ 105,256 Accumulated amortization (68,869 ) — (5,734 ) — (74,603 ) Total net intangible assets with finite lives $ 37,026 $ 1,203 $ (5,734 ) $ (1,842 ) $ 30,653 Intangible assets with indefinite lives: Tradename and other 299,735 853 — (331 ) 300,257 Total intangible assets — net $ 336,761 $ 2,056 $ (5,734 ) $ (2,173 ) $ 330,910 (1) Activity for 2017 represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets. (2) Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments. (3) Amount for intangible assets with finite lives represents preliminary purchase price allocation for theatres acquired in Brazil. Estimated aggregate future amortization expense for intangible assets is as follows ( 1) For the year ended December 31, 2019 $ 4,785 For the year ended December 31, 2020 5,053 For the year ended December 31, 2021 2,904 For the year ended December 31, 2022 2,812 For the year ended December 31, 2023 3,161 Thereafter 11,938 Total $ 30,653 (1) Leases

IMPAIRMENT OF LONG-LIVED ASSETS

IMPAIRMENT OF LONG-LIVED ASSETS	12 Months Ended
	Dec. 31, 2018
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
IMPAIRMENT OF LONG-LIVED ASSETS	7. IMPAIRMENT OF LONG-LIVED ASSETS The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy. The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2016 2017 2018 U.S. theatre properties $ 1,929 $ 5,227 $ 18,597 International theatre properties 907 9,857 13,775 Impairment of long-lived assets $ 2,836 $ 15,084 $ 32,372 The long-lived asset impairment charges recorded during each of the years presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2018, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2018 was approximately $16,295.

Deferred Charges and Other Ass

Deferred Charges and Other Assets - Net	12 Months Ended
	Dec. 31, 2018
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets - Net	8. DEFERRED CHARGES AND OTHER ASSETS — NET As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2017 2018 Long-term prepaid rents (1) $ 7,762 $ 15,943 Construction and other deposits 12,167 8,183 Equipment to be placed in service 13,868 10,466 Other 5,970 6,463 Total $ 39,767 $ 41,055 (1)

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
LONG-TERM DEBT	9. LONG-TERM DEBT As of December 31, long-term debt consisted of the following: December 31, 2017 2018 Cinemark USA, Inc. term loan $ 659,517 $ 652,922 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Other (1) 2,778 1,389 Total long-term debt 1,817,295 1,809,311 Less current portion 7,099 7,984 Less debt issuance costs, net of accumulated amortization of $25,549 and $30,289, respectively 29,815 28,700 Long-term debt, less current portion $ 1,780,381 $ 1,772,627 (1) Represents debt owed to NCM in relation to the joint venture AC JV, LLC. See Note 5. Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a $700,000 term loan and a $100,000 revolving credit line (the “Credit Agreement”). Cinemark USA, Inc. made the following amendments to its Credit Agreement as follows during 2016, 2017 and 2018: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 13, 2016 Reduced term loan interest rate by 0.25% $ 783 $ 249 December 15, 2016 Reduced term loan interest rate by 0.50% $ 2,446 $ 161 June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 March 29, 2018 Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements $ 4,962 $ 1,484 (1) Reflected as a reduction of long term debt on the consolidated balance sheet. (2) Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective. Under the amended Credit Agreement, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. Subsequent to the March 29, 2018 amendment noted above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement. At December 31, 2018, there was $ 652,922 Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries. The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to keep a consolidated net senior secured leverage ratio, as defined in the Credit Agreement, not to exceed 5.0 to 1. As of December 31, 2018, the Company’s actual ratio was 2.9 to 1. The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of December 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,918,142 to its parent company and sole stockholder, Cinemark Holdings, Inc. 4.875% Senior Notes On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023. On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s previously outstanding $200,000 7.375% senior subordinated notes due 2021 (the “7.375% Senior Subordinated Notes”), as discussed below. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023. The Company incurred debt issue costs of approximately $3,702 in connection with the issuance of the additional notes, which, along with the discount of $2,250, are reflected as a reduction of long term debt, net of accumulated amortization, on the consolidated balance sheets as of December 31, 2017 and 2018. The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes. The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,980,550 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2018 was approximately 6.3 to 1. 5.125% Senior Notes On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022. The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes. The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,985,833 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2018 was approximately 6.3 to 1. 7. 375 On June 3, 2011, Cinemark USA, Inc. issued $200,000 aggregate principal amount of 7.375% senior subordinated notes due 2021, at par value (the “Senior Subordinated Notes”). On March 21, 2016, Cinemark USA, Inc. redeemed its Senior Subordinated Notes at a make-whole premium of approximately 104% plus accrued and unpaid interest, utilizing the proceeds from the issuance of the additional $225,000 Cinemark USA, Inc. 4.875% Senior Notes discussed above. As a result of the redemption, the Company wrote-off approximately $2,369 in unamortized debt issue costs, paid a make-whole premium of $9,444 and paid other fees of $1,222, all of which are reflected in loss on debt amendments and refinancing during the year ended December 31, 2016. Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $1,817,295 and $1,809,311 as of December 31, 2017 and 2018, respectively, excluding debt issuance costs of $29,815 and $28,700, respectively. The fair value of the Company’s long term debt was $1,840,918 and $1,774,066 as of December 31, 2017 and 2018, respectively. Covenant Compliance and Debt Maturity As of December 31, 2018, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt. The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2018 matures as follows: 2019 $ 7,984 2020 6,595 2021 6,595 2022 406,595 2023 761,595 Thereafter 619,947 Total $ 1,809,311 Interest Rate Swap Agreements The Company is currently a party to three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2018: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2018 (1) $ 175,000 December 31, 2018 2.751% 1-Month LIBOR December 31, 2022 $ 1,983 $ 137,500 December 31, 2018 2.765% 1-Month LIBOR December 31, 2022 $ 1,624 $ 137,500 December 31, 2018 2.746% 1-Month LIBOR December 31, 2022 $ 1,486 Total $ 5,093 (1) The total estimated fair value of the interest rate swaps of $5,093, net of deferred taxes of $1,243, is reflected in accumulated other comprehensive loss for the year ended December 31, 2018.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value Measurements	10. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2018: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities $ (5,093 ) $ — $ — $ (5,093 ) Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2018 Beginning balance - January 1 $ — Interest rate swaps effective December 31, 2018 5,093 Ending balance - December 31 $ 5,093 (1) Represents interest rate swap liabilities. See Note 11 for further discussion. The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 9). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 11). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2016, 2017 and 2018.

FOREIGN CURRENCY TRANSLATION

FOREIGN CURRENCY TRANSLATION	12 Months Ended
	Dec. 31, 2018
Foreign Currency [Abstract]
FOREIGN CURRENCY TRANSLATION	11. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholder’s equity of $253,282 and $319,007 at December 31, 2017 and 2018, respectively, includes the cumulative foreign currency losses of $253,565 and $315,300, respectively, from translating the financial statements of the Company’s international subsidiaries and the change in fair values of the Company’s interest rate swap agreements designated as hedges. As of December 31, 2018, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters Below is a summary of the impact of translating the financial statements of all of the Company’s international subsidiaries as of and for the years ended December 31, 2016, 2017 and 2018. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2016 2017 2018 2016 2017 2018 Brazil 3.26 3.31 3.88 $ 37,286 $ (4,567 ) $ (34,086 ) Argentina (1) 16.04 18.65 37.68 (13,362 ) (8,200 ) (14,357 ) Colombia 3,000.71 2,936.67 3,249.75 1,278 246 (1,795 ) Chile 679.09 615.97 694.74 1,855 5,672 (8,924 ) Peru 3.45 3.24 3.39 87 2,752 (2,136 ) All other (783 ) (869 ) (955 ) $ 26,361 $ (4,966 ) $ (62,253 ) (1) Amount represents the cumulative comprehensive loss recorded for Argentina through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, beginning July 1, 2018, which was not significant, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statement of income. During the year ended December 31, 2017, the Company reclassified $1,551 of cumulative foreign currency translation adjustments, related to a Canadian subsidiary that was liquidated, from accumulated other comprehensive loss to foreign currency exchange gain (loss) on the consolidated statement of income. During the year ended December 31, 2018, the Company reclassified $518 of cumulative foreign currency translation adjustments, related to the settlement of an intercompany note between a domestic and an international subsidiary, from accumulated other comprehensive loss to foreign currency exchange gain (loss) on the consolidated statement of income.

NONCONTROLLING INTERESTS IN SUB

NONCONTROLLING INTERESTS IN SUBSIDIARIES	12 Months Ended
	Dec. 31, 2018
Noncontrolling Interest [Abstract]
NONCONTROLLING INTERESTS IN SUBSIDIARIES	12. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2017 2018 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,795 $ 8,152 Laredo Theatres – 25% interest (in two theatres) 1,746 2,308 Greeley Ltd. — 49% interest (in one theatre) 843 1,411 Other 509 508 Total $ 11,893 $ 12,379 During December 2016 the Company purchased the remaining 25% noncontrolling interest of one of its Chilean subsidiaries, Flix Impirica S.A. (“Flix Impirica”), for approximately $450 in cash. The increase in the Company’s ownership interest in the Chilean subsidiary was accounted for as an equity transaction in accordance with ASC Topic 810-10-45-23. The Company recorded a decrease in additional paid-in-capital of approximately $27, which represented the difference between the cash paid and the book value of the Chilean subsidiary’s noncontrolling interest account, which was approximately $423. As a result of this transaction, the Company now owns 100% of the shares in Flix Impirica. Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2016 2017 2018 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 265,643 $ 215,735 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest (27 ) — — Net transfers from non-controlling interests (27 ) — — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 256,750 $ 265,643 $ 215,735

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
CAPITAL STOCK	13. CAPITAL STOCK Common and Preferred Stock — Cinemark USA, Inc. has 1,500 shares of Class A common stock and 182,648 shares of Class B common stock outstanding, all of which are held by Cinemark Holdings, Inc. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held. The Company has 1,000,000 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its indentures and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 9 for a discussion of restrictions contained within the debt agreements. Restricted Stock — Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2016, 2017 and 2018: Year Ended Year Ended Year Ended December 31, 2016 December 31, 2017 December 31, 2018 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 757,775 $ 30.73 606,618 $ 33.51 650,581 $ 35.81 Granted 335,707 $ 30.98 246,534 $ 41.70 328,734 $ 38.72 Vested (430,056 ) $ 26.60 (192,230 ) $ 36.26 (250,442 ) $ 31.27 Forfeited (56,808 ) $ 33.81 (10,341 ) $ 33.48 (24,520 ) $ 38.62 Outstanding at December 31 606,618 $ 33.51 650,581 $ 35.81 704,353 $ 38.68 During the year ended December 31, 2018, Cinemark Holdings, Inc. granted 328,734 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $35.80 to $39.26 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year period. Restricted stock granted to employees vests over periods ranging from one year to four years based on continued service. The recipients of restricted stock are entitled to receive dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2016 2017 2018 Compensation expense recognized by the Company during the period $ 7,269 $ 7,528 $ 8,735 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 981 $ 856 $ 920 Fair value of restricted shares held by Company employees that vested during the period $ 13,739 $ 7,255 $ 8,699 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 923 $ 917 $ 802 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 5,167 $ 2,281 $ 1,543 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 388 $ 386 $ 201 As of December 31, 2018, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $15,174, of which $14,758 will be recognized by the Company and $416 of which will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units — During the years ended December 31, 2016, 2017 and 2018, Cinemark Holdings, Inc. granted restricted stock units representing 253,661, 175,634 and 228,194 hypothetical shares of Cinemark Holdings, Inc.’s common stock, respectively, to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement). The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. As an example, if the Company achieves an IRR equal to 9.0% for the 2016 grant, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date. The financial performance factors and respective vesting rates for each of the 2016, 2017 and 2018 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2016 2017 2018 Threshold IRR 6.0% 7.0% 7.0% 33.3% Target IRR 8.0% 9.5% 9.5% 66.6% Maximum IRR 10.0% 13.0% 13.0% 100.0% At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the target IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards granted during 2018. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest. Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2016, 2017 and 2018 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2016 2017 2018 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 84,554 $ 2,522 58,545 $ 2,481 76,065 $ 2,967 at target IRR 169,107 $ 5,044 117,089 $ 4,961 152,129 $ 5,938 at maximum IRR 253,661 $ 7,568 175,634 $ 7,442 228,194 $ 8,906 (1) The grant date fair values for units issued during the years ended December 31, 2016 and 2017 were $29.83 and $42.37, respectively. The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03. Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2016 2017 2018 Number of restricted stock unit awards that vested during the period 213,984 97,115 127,084 Fair value of restricted stock unit awards that vested during the period $ 7,260 $ 4,155 $ 4,846 Accumulated dividends paid upon vesting of restricted stock unit awards $ 662 $ 558 $ 526 Compensation expense recognized during the period $ 5,144 $ 4,297 $ 4,681 Income tax benefit recognized upon vesting of restricted stock unit awards $ 3,049 $ 1,745 $ 708 During the year ended December 31, 2016, the Compensation Committee of the Board of Directors approved a modification to the 2015 restricted stock unit grants. The modification resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on the Company’s stock price at the date of modification, which was $37.98. The modifications resulted in incremental compensation expense of approximately $562 for the year ended December 31, 2016. As of December 31, 2018, the Company had restricted stock units outstanding that represented a total 594,266 hypothetical shares of common stock, net of actual cumulative forfeitures of 18,667 units, assuming the maximum IRR is achieved for all of the outstanding restricted stock unit awards. As of December 31, 2018, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $8,416, which reflects the maximum IRR level that was achieved for the 2015 grant, an IRR level of 7.2% that was achieved for the 2016 grant, an IRR level of 11.2% that is estimated for the 2017 grant and an IRR level of 9.5% that is estimated for the 2018 grants. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	14. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2016 2017 2018 Cash paid for interest $ 108,101 $ 99,232 $ 98,411 Cash paid for income taxes, net of refunds received $ 93,368 $ 95,043 $ 64,199 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (29,471 ) $ 9,349 $ (5,728 ) Theatre properties acquired under capital lease $ 33,282 $ 46,727 $ 18,851 Investment in NCM – receipt of common units (see Note 4) $ 11,111 $ 18,363 $ 5,012 Interest expense - NCM (see Note 3) $ — $ — $ (19,724 ) (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2017 and 2018 were $31,276 and $37,004, respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	15. INCOME TAXES On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries, and (4) created new taxes on certain foreign-sourced earnings. As of December 31, 2018, the amounts recorded for the Tax Act are final for the 2017 transition tax, the re-measurement of deferred taxes, and the Company’s reassessment of valuation allowances. The Company recorded a net additional charge as a result of the Tax Act and its recently issued guidance of $19,180, all non-cash, including a true up of the re-measurement of deferred tax liabilities using the lower U.S. corporate income tax rate and a reduction in a deferred tax asset with regard to foreign tax credit carryforwards. The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2016 2017 2018 Income before income taxes: U.S. $ 277,474 $ 282,896 $ 292,238 Foreign 85,890 64,842 21,007 Total $ 363,364 $ 347,738 $ 313,245 Current and deferred income taxes were as follows: Year Ended December 31, 2016 2017 2018 Current: Federal $ 66,210 $ 55,224 $ 47,333 Foreign 32,047 29,306 11,822 State 12,061 10,741 13,690 Total current expense $ 110,318 $ 95,271 $ 72,845 Deferred: Federal $ (13,667 ) $ (14,046 ) $ 27,055 Foreign 1,674 (4,270 ) (6,166 ) State 6,526 3,301 2,298 Total deferred taxes $ (5,467 ) $ (15,015 ) $ 23,187 Income taxes $ 104,851 $ 80,256 $ 96,032 A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2016 2017 2018 Computed statutory tax expense $ 127,176 $ 121,708 $ 65,781 Foreign inflation adjustments (281 ) — — State and local income taxes, net of federal income tax impact 12,081 12,857 12,686 Foreign losses not benefited and changes in valuation allowance (34,757 ) 249 822 Foreign tax rate differential (942 ) (245 ) 2,235 Foreign dividends 68,684 13,662 — Foreign tax credits (62,815 ) (21,647 ) 3,927 Impacts related to 2017 Tax Act (1)(2) — (44,889 ) 19,180 Changes in uncertain tax positions 921 983 (6,139 ) Other — net (5,216 ) (2,422 ) (2,460 ) Income taxes $ 104,851 $ 80,256 $ 96,032 (1) The year ended December 31, 2018 includes a one-time true-up of deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267. (2) The year ended December 31, 2017 includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433. As of December 31, 2018, all earnings invested offshore subject to the Tax Act have been included in the transition tax. As of December 31, 2018, the Company had approximately $415,323 of accumulated undistributed earnings and profits, approximately $373,768 of which was subject to the one-time transition tax pursuant to the Tax Act. Any additional tax due on the repatriation of previously taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in its foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2017 and 2018 consisted of the following: December 31, 2017 2018 Deferred liabilities: Theatre properties and equipment $ 147,208 $ 158,797 Intangible asset — other 30,770 33,561 Intangible asset — tradenames 72,967 73,261 Investment in partnerships 67,449 63,217 Total deferred liabilities 318,394 328,836 Deferred assets: Deferred lease expenses 14,714 13,464 Exchange loss 220 1,306 Deferred revenue - NCM 85,816 70,688 Capital lease obligations 67,369 63,895 Tax impact of items in accumulated other comprehensive income — 2,237 Other tax loss carryforwards 15,564 15,608 Other tax credit carryforwards 38,436 42,989 Other expenses, not currently deductible for tax purposes 13,801 26,776 Total deferred assets 235,920 236,963 Net deferred income tax liability before valuation allowance 82,474 91,873 Valuation allowance against deferred assets – non-current 35,246 54,725 Net deferred income tax liability $ 117,720 $ 146,598 Net deferred tax (asset) liability — Foreign $ 3,073 $ (5,449 ) Net deferred tax liability — U.S. 114,647 152,047 Total $ 117,720 $ 146,598 A significant portion of our foreign tax credit carryforwards expire in 2023. Some foreign net operating losses expired in 2018; however, some losses may be carried forward indefinitely. State net operating losses may be carried forward for periods of between five and twenty years with the last expiring year being 2037. The Company’s valuation allowance changed from $35,246 at December 31, 2017 to $54,725 at December 31, 2018 (see Note 19). The increase was a result of recently issued guidance for the Tax Act and the impact on the estimated usage of foreign tax credit carryforwards before their expiration. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2016, 2017 and 2018: Year Ended December 31, 2016 2017 2018 Balance at January 1, $ 17,133 $ 17,403 $ 18,266 Gross increases - tax positions in prior periods 13 92 — Gross decreases - tax positions in prior periods — (12 ) (143 ) Gross increases - current period tax positions 923 265 424 Settlements (924 ) (177 ) (7,191 ) Foreign currency translation adjustments 258 695 (795 ) Balance at December 31, $ 17,403 $ 18,266 $ 10,561 The Company had $20,231 and $13,953 of unrecognized tax benefits, including interest and penalties, as of December 31, 2017 and 2018, respectively. Of these amounts, $20,231 and $13,953 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2017 and 2018, respectively. The Company had $5,288 and $3,390 accrued for interest and penalties as of December 31, 2017 and 2018, respectively. The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and in certain state and foreign jurisdictions and are routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2015. Additionally, the Company began and concluded an audit from the Internal Revenue Service for the year 2016, with no changes. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2014. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2005. The Company is currently under audit in the non-U.S. tax jurisdiction of Brazil. The Company concluded an audit in Chile in 2018 and recorded a tax benefit of $6,802.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	16. COMMITMENTS AND CONTINGENCIES Leases — The Company conducts a significant part of its theatre operations in leased properties under noncancelable leases with terms generally ranging from 10 to 25 years. In addition to the minimum annual lease payments, some of the leases provide for contingent rentals based on operating results of the theatre and some require the payment of taxes, insurance and other costs applicable to the property. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. A liability for deferred lease expenses of $40,929 and $39,235 at December 31, 2017 and 2018, respectively, has been provided to account for lease expenses on a straight-line basis, where lease payments are not made on such a basis. Year Ended December 31, 2016 2017 2018 Fixed rent expense $ 242,927 $ 247,908 $ 248,543 Contingent rent and other facility lease expenses 78,367 80,289 74,773 Total facility lease expense $ 321,294 $ 328,197 $ 323,316 Future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 are as follows (1) Operating Capital Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467 (1) Represents amounts before the adoption of ASC Topic 842 – Leases . See Note 2 for discussion of the expected impact of adoption. Employment Agreements — As of December 31, 2018, the Company had employment agreements with Lee Roy Mitchell, Mark Zoradi, Sean Gamble, Valmir Fernandes and Michael Cavalier. The employment agreements are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Company’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee within the first 90 days of the fiscal year. Effective February 20, 2018, the Company and Mr. Zoradi amended his employment agreement extending the term to December 31, 2019. Effective January 2, 2018, Robert Carmony, Executive Vice President – Innovation, retired from the Company and his employment agreement was terminated. Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $6,380 and $5,076 were made during 2017 and 2018, respectively. A liability of approximately $1,374 was recorded at December 31, 2018 for employer contribution payments to be made in 2019 for the remaining amounts owed for plan year 2018. Silken Brown v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for penalties and attorney's fees arising from alleged violations of the California wage statement law. The claim is also asserted as a representative action under the California Private Attorney General Act (PAGA) for penalties. The Court granted class certification. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims. The Company denies any violation of law; however, to avoid the cost and uncertainty associated with litigation the Company and the plaintiff entered into a Joint Stipulation of Class Action Settlement and Release of Claims (the “Settlement Agreement”) to fully and finally dismiss all claims that would be brought in the case. The Settlement Agreement must be approved by the Court. During the year ended December 31, 2018, the Company recorded a litigation reserve based on the proposed Settlement Agreement in loss on disposal of assets and other on the consolidated income statement. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles . Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During the year ended December 31, 2018, the Company recorded a litigation reserve based on an estimate of the jury award, which is reflected in loss on disposal of assets and other on the consolidated income statement. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company intends to appeal the judgment. Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
SEGMENTS	17. SEGMENTS The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, because we believe it provides management and investors with additional information to measure the Company’s performance and liquidity, estimate the Company’s value and evaluate the Company’s ability to service debt. In addition, the Company uses Adjusted EBITDA for incentive compensation purposes. The Company does not report asset information by segment because that information is not used to evaluate Company performance or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2016 2017 2018 Revenues U.S. $ 2,230,693 $ 2,236,237 $ 2,551,719 International 701,573 769,436 682,778 Eliminations (13,501 ) (14,126 ) (12,762 ) Total revenues $ 2,918,765 $ 2,991,547 $ 3,221,735 Adjusted EBITDA U.S. $ 550,150 $ 559,693 $ 650,189 International 157,690 165,576 132,941 Total Adjusted EBITDA $ 707,840 $ 725,269 $ 783,130 Capital expenditures U.S. $ 242,271 $ 321,040 $ 270,870 International 84,637 59,822 75,203 Total capital expenditures $ 326,908 $ 380,862 $ 346,073 (1) Distributions from equity investees are reported entirely within the U.S. operating segment. The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2016 2017 2018 Net income $ 258,513 $ 267,482 $ 217,213 Add (deduct): Income taxes 104,851 80,256 96,032 Interest expense (1) 108,313 105,918 109,994 Loss on debt amendments and refinancing 13,445 521 1,484 Other income (2) (44,813 ) (43,121 ) (18,450 ) Other cash distributions from equity investees (3) 21,916 25,973 30,143 Depreciation and amortization 209,071 237,513 261,162 Impairment of long-lived assets 2,836 15,084 32,372 Loss on disposal of assets and other 20,459 22,812 38,702 Deferred lease expenses (990 ) (1,268 ) (1,320 ) Amortization of long-term prepaid rents 1,826 2,274 2,382 Share based awards compensation expense $ 12,413 $ 11,825 $ 13,416 Adjusted EBITDA $ 707,840 $ 725,269 $ 783,130 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM. (3) Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances. Financial Information About Geographic Area Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2016 2017 2018 Revenues U.S. $ 2,230,693 $ 2,236,237 $ 2,551,719 Brazil 304,407 341,485 283,009 Other international countries 397,166 427,951 399,769 Eliminations (13,501 ) (14,126 ) (12,762 ) Total $ 2,918,765 $ 2,991,547 $ 3,221,735 December 31, 2017 December 31, 2018 Theatre Properties and Equipment-net U.S. $ 1,439,168 $ 1,479,603 Brazil 179,669 140,570 Other international countries 209,217 212,960 Total $ 1,828,054 $ 1,833,133

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	18. RELATED PARTY TRANSACTIONS The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $506, $586 and $654 of management fee revenues during the years ended December 31, 2016, 2017 and 2018, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2016, 2017 and 2018, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $110, $131 and $68, respectively. The Company holds events for its employees and their families at Pinstack, an entertainment facility, at various times throughout the year. Pinstack is majority-owned by Mr. Mitchell and his wife, Tandy Mitchell. In connection with the event, the Company paid Pinstack approximately $70, $36 and $5 during the years ended December 31, 2016, 2017 and 2018, respectively. The Company currently leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2016, 2017 and 2018, the Company paid total rent of approximately $21,124, $22,483 and $23,447, respectively, to Syufy. The Company has paid certain fees and expenses on behalf of its parent, Cinemark Holdings, Inc. and Cinemark Holdings, Inc. has paid income taxes on behalf of the Company. The Company paid cash dividends to Cinemark Holdings, Inc. of $124,900, $134,500 and $148,750 during the years ended December 31, 2016, 2017 and 2018, respectively. The Company had a receivable from Cinemark Holdings, Inc. of $14,581 and $19,530 as of December 31, 2016, 2017 and 2018, respectively. The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 5 for further discussion.

VALUATION AND QUALIFYING ACCOUN

VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2018
Valuation And Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTS	19. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2016, 2017 and 2018 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2016 $ 50,636 Additions 483 Deductions (36,595 ) Balance at December 31, 2016 $ 14,524 Additions 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 Additions ( 1 ) 22,005 Deductions (2,526 ) Balance at December 31, 2018 $ 54,725 (1) A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Financi

Condensed Consolidating Financial Information of Subsidiary Guarantors	12 Months Ended
	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Condensed Consolidating Financial Information of Subsidiary Guarantors	20. Condensed Consolidating Financial Information of Subsidiary Guarantors As of December 31, 2018, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial information presents: a. Condensed consolidating balance sheet information as of December 31, 2017 and December 31, 2018 and condensed consolidating statements of income information, condensed consolidating statements of comprehensive income information and condensed consolidating statements of cash flows information for the years ended December 31, 2016, 2017 and 2018. b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 Other current assets 59,661 17,841 76,789 (19,270 ) 135,021 Accounts receivable from parent or subsidiaries 117,972 119,616 — (223,007 ) 14,581 Total current assets 308,223 318,080 287,991 (242,277 ) 672,017 Theatre properties and equipment - net 650,783 765,500 411,771 — 1,828,054 Investment in subsidiaries 1,691,626 121,795 — (1,813,421 ) — Other assets 1,427,328 134,845 536,816 (113,720 ) 1,985,269 Total assets $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 Liabilities and equity Current liabilities Current portion of long-term debt $ 5,710 $ — $ 1,389 $ — $ 7,099 Current portion of capital lease obligations 9,532 11,124 4,855 — 25,511 Accounts payable and accrued expenses 215,580 116,409 110,089 (6,402 ) 435,676 Accounts payable to parent or subsidiaries — — 223,007 (223,007 ) — Total current liabilities 230,822 127,533 339,340 (229,409 ) 468,286 Long-term liabilities Long-term debt, less current portion 1,878,992 — 11,211 (109,822 ) 1,780,381 Capital lease obligations, less current portion 132,189 75,767 43,195 — 251,151 Other long-term liabilities and deferrals 426,355 60,567 93,871 (16,766 ) 564,027 Total long-term liabilities 2,437,536 136,334 148,277 (126,588 ) 2,595,559 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,360,059 618,985 726,830 (1,345,815 ) 1,360,059 Total Cinemark USA, Inc. stockholder's equity 1,409,602 1,076,353 737,068 (1,813,421 ) 1,409,602 Noncontrolling interests — — 11,893 — 11,893 Total equity 1,409,602 1,076,353 748,961 (1,813,421 ) 1,421,495 Total liabilities and equity $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) - Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) - Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 413,177 60,137 77,844 (6,137 ) 545,021 Total long-term liabilities 2,409,133 119,676 135,398 (114,092 ) 2,550,115 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,415,262 673,174 723,319 (1,396,494 ) 1,415,261 Total Cinemark USA, Inc. stockholder's equity 1,464,805 1,130,542 733,557 (1,864,100 ) 1,464,804 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,464,805 1,130,542 745,936 (1,864,100 ) 1,477,183 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on disposal of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on disposal of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,192,478 $ 1,362,043 $ 723,804 $ (56,590 ) $ 3,221,735 Cost of operations Theatre operating expenses 916,726 933,858 541,981 (56,590 ) 2,335,975 General and administrative expenses 11,497 100,407 50,736 — 162,640 Depreciation and amortization 89,429 99,627 72,106 — 261,162 Impairment of long-lived assets 4,118 13,612 14,642 — 32,372 Loss on disposal of assets and other 13,321 23,337 2,044 — 38,702 Total cost of operations 1,035,091 1,170,841 681,509 (56,590 ) 2,830,851 Operating income 157,387 191,202 42,295 - 390,884 Other income (expense) Interest expense (97,585 ) (6,520 ) (7,266 ) 1,377 (109,994 ) Loss on debt amendments and refinancing (1,484 ) — — — (1,484 ) Distributions from NCM — — 15,389 — 15,389 Interest expense - NCM (19,724 ) — — — (19,724 ) Equity in income of affiliates 183,463 (12,561 ) 33,167 (164,827 ) 39,242 Other income 4,287 (14 ) (3,964 ) (1,377 ) (1,068 ) Total other income 68,957 (19,095 ) 37,326 (164,827 ) (77,639 ) Income before income taxes 226,344 172,107 79,621 (164,827 ) 313,245 Income taxes 10,608 68,624 16,800 - 96,032 Net income 215,736 103,483 62,821 (164,827 ) 217,213 Less: Net income attributable to noncontrolling interests — — 1,478 — 1,478 Net income attributable to Cinemark USA, Inc. $ 215,736 $ 103,483 $ 61,343 $ (164,827 ) $ 215,735 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income, net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $138 234 — — — 234 Other comprehensive income of equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive income (loss), net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 215,736 $ 103,483 $ 62,821 $ (164,827 ) $ 217,213 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, net of settlements (3,851 ) — — — (3,851 ) Other comprehensive loss of equity method investments (139 ) — (139 ) 139 (139 ) Foreign currency translation adjustments (62,253 ) — (62,253 ) 62,253 (62,253 ) Total other comprehensive loss, net of tax (66,243 ) — (62,392 ) 62,392 (66,243 ) Total comprehensive income, net of tax $ 149,493 $ 103,483 $ 429 $ (102,435 ) $ 150,970 Comprehensive income attributable to noncontrolling interests — — (1,478 ) — (1,478 ) Comprehensive income attributable to Cinemark USA, Inc. $ 149,493 $ 103,483 $ (1,049 ) $ (102,435 ) $ 149,492 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (178,147 ) 55,128 53,381 301,946 232,308 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 232,715 102,817 126,727 — 462,259 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the U.S. (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Fees paid related to debt amendments (11,076 ) — — — (11,076 ) Intercompany loan proceeds — — 4,455 (4,455 ) - Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (140,426 ) (16,839 ) (257,083 ) 251,227 (163,121 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (122,559 ) 71,023 33,515 270,189 252,168 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash provided by operating activities 161,307 187,884 179,193 — 528,384 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) - (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash used for investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing Activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Fees paid related to debt amendments (521 ) — — — (521 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash provided by financing activities (148,436 ) (129,450 ) (9,016 ) 129,473 (157,429 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 215,736 $ 103,483 $ 62,821 $ (164,827 ) $ 217,213 Adjustments to reconcile net income to cash provided by operating activities (36,894 ) 162,811 55,915 164,827 346,659 Changes in assets and liabilities 229,325 (233,263 ) (3,635 ) — (7,573 ) Net cash provided by operating activities 408,167 33,031 115,101 — 556,299 Investing activities Additions to theatre properties and equipment (91,244 ) (173,042 ) (81,787 ) — (346,073 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 2,025 651 — 3,920 Proceeds from intercompany note repayments 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) 361 — (19,535 ) Net cash used for investing activities (166,526 ) (190,913 ) (92,064 ) (1,867 ) (451,370 ) Financing activities Dividends paid to parent (148,750 ) — — — (148,750 ) Repayments of long-term debt (7,984 ) — — — (7,984 ) Payment of debt issue costs (5,218 ) — — — (5,218 ) Payments on capital leases (11,610 ) (8,950 ) (4,793 ) — (25,353 ) Payments on intercompany loans — - (1,867 ) 1,867 — Other (704 ) (2,905 ) (992 ) — (4,601 ) Net cash used for financing activities (174,266 ) (11,855 ) (7,652 ) 1,867 (191,906 ) Effect of exchange rate changes on cash and cash equivalents — — (9,222 ) — (9,222 ) Increase (decrease) in cash and cash equivalents 67,375 (169,737 ) 6,163 — (96,199 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 * * * * *

Unaudited Supplemental Schedule

Unaudited Supplemental Schedules	12 Months Ended
	Dec. 31, 2018
Supplemental Financial Information For Indentures [Abstract]
Unaudited Supplemental Schedules	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES DECEMBER 31, 2018 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 370,460 $ 55,756 $ — $ 426,216 Other current assets 267,077 (106,143 ) (8,607 ) 152,327 Total current assets 637,537 (50,387 ) (8,607 ) 578,543 Theatre properties and equipment, net 1,833,133 — — 1,833,133 Other assets 1,916,169 522,225 (348,719 ) 2,089,675 Total assets $ 4,386,839 $ 471,838 $ (357,326 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 27,065 — — 27,065 Accounts payable and accrued expenses 447,610 1 (8,607 ) 439,004 Total current liabilities 481,270 1,390 (8,607 ) 474,053 Long-term liabilities Long-term debt, less current portion 2,014,327 - (241,700 ) 1,772,627 Capital lease obligations, less current portion 232,467 — — 232,467 Other long-term liabilities and deferrals 484,528 60,493 — 545,021 Total long-term liabilities 2,731,322 60,493 (241,700 ) 2,550,115 Commitments and contingencies Equity 1,174,247 409,955 (107,019 ) 1,477,183 Total liabilities and equity $ 4,386,839 $ 471,838 $ (357,326 ) $ 4,501,351 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES YEAR ENDED DECEMBER 31, 2018 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Revenues $ 3,221,735 $ — $ — $ 3,221,735 Cost of operations — Theatre operating costs 2,335,975 — — 2,335,975 General and administrative expenses 162,645 (5 ) — 162,640 Depreciation and amortization 261,162 — — 261,162 Impairment of long-lived assets 32,372 — — 32,372 Loss on sale of assets and other 38,702 — — 38,702 Total cost of operations 2,830,856 (5 ) — 2,830,851 Operating income (loss) 390,879 5 — 390,884 Other income (expense) (154,545 ) 76,906 — (77,639 ) Income before income taxes 236,334 76,911 — 313,245 Income taxes 72,086 23,946 — 96,032 Net income 164,248 52,965 — 217,213 Less: Net income attributable to noncontrolling interests 1,478 — — 1,478 Net income attributable to Cinemark USA, Inc. $ 162,770 $ 52,965 $ — $ 215,735 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Net income $ 164,248 $ 52,965 $ — $ 217,213 Other comprehensive income, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, net of settlements (3,851 ) — — (3,851 ) Other comprehensive loss in equity method investments — (139 ) — (139 ) Foreign currency translation adjustments (62,253 ) — — (62,253 ) Total other comprehensive income (loss), net of tax (66,104 ) (139 ) — (66,243 ) Total comprehensive income, net of tax 98,144 52,826 — 150,970 Comprehensive income attributable to noncontrolling interests (1,478 ) — — (1,478 ) Comprehensive income attributable to Cinemark USA, Inc. $ 96,666 $ 52,826 $ — $ 149,492 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES YEAR ENDED DECEMBER 31, 2018 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Operating activities Net income $ 164,248 $ 52,965 $ - $ 217,213 Adjustments to reconcile net income to cash provided by operating activities 343,793 2,866 — 346,659 Changes in assets and liabilities 32,060 (39,633 ) — (7,573 ) Net cash provided by operating activities 540,101 16,198 — 556,299 Investing activities Additions to theatre properties and equipment and other (346,073 ) — — (346,073 ) Proceeds from sale of theatre properties and equipment and other 3,920 — — 3,920 Acquisition of theatres in international markets, net of cash acquired (11,289 ) — — (11,289 ) Loans to affiliates - (21,700 ) 21,700 — Acquisition of NCM common units (78,393 ) — — (78,393 ) Investment in joint ventures and other (19,896 ) 361 — (19,535 ) Net cash used for investing activities (451,731 ) (21,339 ) 21,700 (451,370 ) Financing activities Dividends paid to parent (148,750 ) — — (148,750 ) Borrowings from affiliate 21,700 — (21,700 ) — Repayments on long-term debt (7,984 ) - — (7,984 ) Payment of debt issue costs (5,218 ) - — (5,218 ) Payments on capital leases (25,353 ) — — (25,353 ) Other (4,601 ) — — (4,601 ) Net cash used for financing activities (170,206 ) — (21,700 ) (191,906 ) Effect of exchange rate changes on cash and cash equivalents (9,222 ) — — (9,222 ) Decrease in cash and cash equivalents (91,058 ) (5,141 ) — (96,199 ) Cash and cash equivalents: Beginning of year 461,518 60,897 — 522,415 End of year $ 370,460 $ 55,756 $ — $ 426,216 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Business	Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay.
Principles of Consolidation	Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds, certificates of deposit or other similar funds.
Accounts Receivable	Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, receivables related to discounted tickets and gift cards sold third party to retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.
Inventories	Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market.
Theatre Properties and Equipment	Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its impairment assessment. Long-lived assets are evaluated for impairment on a theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2016, 2017 and 2018. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 7 for further discussion.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill. A quantitative analysis requires the Company to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017 and 2018. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017 and 2018. A qualitative assessment includes consideration of historical and expected future industry performance, estimated future performance of the Company, current industry trading multiples and other economic factors, and a review of current carrying values to estimated fair values as determined during our most recent quantitative assessment. We performed a qualitative assessment for all reporting units for the year ended December 31, 2016. We performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, we performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. We did not record any goodwill impairment charges as a result of the assessments performed during the years ended December 31, 2016, 2017 and 2018. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment. During the year ended December 31, 2016, the Company performed a quantitative tradename impairment assessment for our tradename in Ecuador and performed a qualitative tradename impairment analysis for all other tradename intangible assets. During the year ended December 31, 2017, the Company performed quantitative tradename impairment evaluations for all of its tradename assets. During the year ended December 31, 2018, the Company performed a qualitative tradename impairment analysis for all of its tradename assets. As a result of the analysis performed during each year, no impairment charges were recorded related to tradename intangible assets for the years ended December 31, 2016, 2017 and 2018. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately two to eight years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is two years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately one to eighteen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eight years.
Deferred Charges and Other Assets	Deferred Charges and Other Assets — Deferred charges and other assets consist of long-term prepaid rents, construction and other deposits, equipment to be placed in service, and other assets of a long-term nature. Long-term prepaid rents represent prepayments of rent on operating leases, which are recognized as facility lease expense over the period for which the rent was paid in advance as outlined in the lease agreements. The remaining amortization periods generally range from one to seventeen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements.
Lease Accounting	Lease Accounting — The Company evaluates each lease for classification as either a capital lease or an operating lease. The Company records the lease as a capital lease at its inception if 1) the present value of future minimum lease payments exceeds 90% of the leased property’s estimated fair value; 2) the lease term exceeds 75% of the property’s estimated useful life; 3) the lease contains a bargain purchase option; or 4) ownership transfers to the Company at the end of the lease. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent expense impact of an operating lease upon inception of the lease. For some newly built theatres, the landlord is responsible for constructing the theatre using guidelines and specifications agreed to by the Company and assumes substantially all of the risks of construction. For other theatres, the Company is responsible for managing construction of the theatre and the landlord contributes an agreed upon amount toward the costs of construction. If the Company concludes that it has substantially all of the construction period risks, it considers itself the owner of the property during the construction period. At the end of the construction period, the Company determines if the transaction qualifies for sale-leaseback accounting treatment in regards to lease classification. If the Company receives a lease incentive payment from a landlord, the Company records the proceeds as a deferred lease incentive liability and amortizes the liability as a reduction in rent expense over the initial term of the lease if a new theatre, or over the remaining lease term if an existing theatre. See Note 2 for discussion of the expected impact of new lease accounting pronouncements.
Deferred Revenues	Deferred Revenues — Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the advances are earned, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as such revenues are earned in accordance with the terms of the contracts. In addition, the Company records deferred revenues for sales of gift cards and discounted ticket vouchers, as well as for proceeds received from its monthly subscription program, annual membership fees for certain of its loyalty programs and for points issued to customers under other loyalty programs. See Note 3 for further discussion of revenue recognition and Note 4 for discussion of deferred revenue – NCM.
Self-Insurance Reserves	Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2016, 2017 and 2018, general liability claims were capped at $100, $250 and $250, respectively, per occurrence with aggregate annual caps of approximately $3,350, $3,900 and $4,750, respectively. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. In the U.S., the Company was fully insured for workers compensation claims during the year ended December 31, 2016. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000 for the years ended December 31, 2017 and 2018. The Company was also self-insured for domestic medical claims up to $150, $250 and $250 per occurrence for the years ended December 31, 2016, 2017 and 2018, respectively. As of December 31, 2017 and 2018, the Company’s insurance reserves were $8,252 and $10,827, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets
Revenue and Expense Recognition	Revenue and Expense Recognition — See Note 3 for discussion of revenue recognition. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final settlement rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at the time of settlement.
Loyalty Programs	Loyalty Programs – The Company launched its domestic app-based loyalty program, Connections, in February 2016. Customers earn points for various transactions as tracked within the app. Points may be redeemed for movie tickets, concessions items, concession discounts and experiential rewards, each of which are offered for limited periods of time and at varying times during the year. For the years ended December 31, 2016 and 2017, the Company applied the incremental cost approach to accounting for the rewards earned, as it determined that the values of the rewards offered to the customer are insignificant to the original transactions required to earn such rewards. The Company also has loyalty programs in certain of its international markets, which generally consist of the customer paying a membership fee in exchange for discounts during the membership period. Effective January 1, 2018, the Company adopted ASC Topic 606 and now accounts for its points-based loyalty programs by deferring a portion of the revenue associated with the transaction that earned such points. See Note 3 for discussion of revenue recognition as it relates to the Company’s loyalty programs.
Accounting for Share Based Awards	Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 13 for discussion of the Company’s share based awards and related compensation expense.
Income Taxes	Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. U.S. Tax Reform On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries, and (4) created new taxes on certain foreign-sourced earnings. As of December 31, 2018, the amounts recorded for the Tax Act are final for the 2017 transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. See further discussion at Note 15.
Segments	Segments — For the years ended December 31, 2016, 2017 and 2018, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 17.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Foreign Currency Translations	Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 11 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2016, 2017 and 2018. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.
Fair Value Measurements	Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 10 for a discussion of our fair value measurements for the year ended December 31, 2018.
Acquisitions	Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Estimated Useful Life of Assets	Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1)
Amortization Method Used for Intangible Assets	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately two to eight years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is two years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately one to eighteen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eight years.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition	The following table presents revenues for the year ended December 31, 2018, disaggregated based on major type of good or service and by reportable operating segment. Twelve Months Ended December 31, 2018 U.S. International Operating Operating Major Goods/Services Segment (1) Segment Consolidated Admissions revenues $ 1,461,151 $ 373,022 $ 1,834,173 Concession revenues 892,391 216,402 1,108,793 Screen advertising and promotional revenues 78,591 61,269 139,860 Other revenues 106,824 32,085 138,909 Total revenues $ 2,538,957 $ 682,778 $ 3,221,735 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations. The following table presents revenues for the year ended December 31, 2018, disaggregated based on timing of revenue recognition (as discussed above). Twelve Months Ended December 31, 2018 U.S. International Operating Operating Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,453,313 $ 608,347 $ 3,061,660 Goods and services transferred over time 85,644 74,431 160,075 Total $ 2,538,957 $ 682,778 $ 3,221,735 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations.
Changes in Deferred Revenues	The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2018. Deferred Revenues Deferred Revenue - NCM Other Deferred Revenues (1) Total Balance at January 1, 2018 $ 351,706 $ 86,498 $ 438,204 Impact of adoption of ASC Topic 606 (53,605 ) — (53,605 ) Amounts recognized as accounts receivable — 6,921 6,921 Cash received from customers in advance — 156,237 156,237 Common units received from NCM (see Note 6) 5,012 — 5,012 Revenue recognized during period (15,764 ) (141,176 ) (156,940 ) Foreign currency translation adjustments — (2,405 ) (2,405 ) Balance at December 31, 2018 $ 287,349 $ 106,075 $ 393,424 (1) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet.
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2018 and when the Company expects to recognize this revenue. Twelve Months Ended December 31, Remaining Performance Obligations 2019 2020 2021 2022 2023 Thereafter Total Deferred revenue - NCM $ 15,831 $ 15,831 $ 15,831 $ 15,831 $ 15,831 $ 208,194 $ 287,349 Deferred revenue - other 89,523 16,146 207 199 — — 106,075 Total $ 105,354 $ 31,977 $ 16,038 $ 16,030 $ 15,831 $ 208,194 $ 393,424
Adoption of ASC Topic 606
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Summary of Impact Upon Adoption of ASC Topic 606 on Statements of Income and Cash Flows and Balance Sheet	The significant changes discussed above had the following impact on the Company’s statements of income and cash flows for the year ended December 31, 2018: Without Adoption of ASC 606 Impact of Adoption of ASC 606 As Reported Statement of income: Admissions revenues $ 1,839,723 $ (5,550 ) $ 1,834,173 Concession revenues $ 1,110,703 $ (1,910 ) $ 1,108,793 Other revenues $ 161,743 $ 117,026 $ 278,769 Utilities and other expense $ 354,740 $ 93,330 $ 448,070 Interest expense - NCM $ — $ 19,724 $ 19,724 Statement of cash flows: Amortization of deferred revenues, deferred lease incentives and other $ (17,602 ) $ (4,104 ) $ (21,706 ) Changes in other assets and liabilities - Other long-term liabilities $ 4,375 $ 7,592 $ 11,967 The impact of adoption of ASC 606 on the Company’s balance sheet as of December 31, 2018 was as follows: Without Adoption of ASC 606 Impact of Adoption of ASC 606 As Reported Balance sheet line items: Deferred revenue - NCM (1) $ 345,058 $ (57,709 ) $ 287,349 Long-term deferred tax liability $ 142,547 $ 13,079 $ 155,626 Other long-term liabilities $ 41,839 $ 7,592 $ 49,431 Retained earnings $ 440,054 $ 40,526 $ 480,580 (1) Includes the cumulative effect of accounting change of $53,605 recorded on January 1, 2018 and the full year impact of the change in amortization method of $4,104 during the year ended December 31, 2018.

Investment in National CineMe_2

Investment in National CineMedia LLC (Tables) - NCM	12 Months Ended
	Dec. 31, 2018
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2016, 2017 and 2018: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2016 annual common unit adjustment 3/31/2016 753,598 $ 11,111 2017 annual common unit adjustment 3/31/2017 1,487,218 $ 18,363 2018 annual common unit adjustment 3/29/2018 908,042 $ 5,012
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 3 for discussion of impact of new revenue recognition accounting pronouncements. Investment in NCM Deferred Revenue Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (3) Cash Received (Paid) Balance as of January 1, 2016 $ 183,755 $ (342,134 ) Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the twelve months ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of deferred revenue — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 Impact of adoption of ASC Topic 606 (2) — 53,605 $ — $ — $ — $ — $ — Receipt of common units due to annual common unit adjustment 5,012 (5,012 ) — — — — — Purchase of additional common units 78,393 — — — — — — Revenues earned under ESA (1)(3) — — — — (31,867 ) 19,724 12,143 Receipt of excess cash distributions (19,786 ) — (13,231 ) — — — 33,017 Receipt under tax receivable agreement (2,419 ) — (2,158 ) — — — 4,577 Equity in earnings 13,842 — — (13,842 ) — — — Amortization of deferred revenue (2) — 15,764 — — (15,764 ) — — Balance as of and for the twelve months ended December 31, 2018 $ 275,592 $ (287,349 ) $ (15,389 ) $ (13,842 ) $ (47,631 ) $ 19,724 $ 49,737 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $10,523, $11,110 and $11,965 for the years ended December 31, 2016, 2017 and 2018, respectively. (2) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings. See Note 3 for further discussion of the impact of the adoption of ASC Topic 606. (3) Reflects the impact of significant financing component related to amounts received in advance under the ESA and CUA agreement. See Note 3.
Summary Financial Information	The tables below present summary financial information for NCM for the periods indicated: Year Ended Year Ended Year Ended December 29, 2016 December 28, 2017 December 27, 2018 Revenues $ 447,600 $ 426,100 $ 441,400 Operating income $ 173,000 $ 153,900 $ 154,300 Net income $ 109,300 $ 101,900 $ 98,400 As of As of December 28, 2017 December 27, 2018 Current assets $ 174,400 $ 172,700 Noncurrent assets $ 758,300 $ 726,800 Current liabilities $ 123,300 $ 115,200 Noncurrent liabilities $ 925,400 $ 924,900 Members' deficit $ (116,000 ) $ (140,600 )

Other Investments (Tables)

Other Investments (Tables)	12 Months Ended
	Dec. 31, 2018
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP RealD AC LLC DCDC FE Concepts Other Total Balance at January 1, 2016 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ — $ 663 $ 94,973 Cash contributions 717 — — — — 415 1,132 Equity in income 21,434 — 311 870 — — 22,615 Equity in comprehensive income 89 — — — — — 89 Sale of investment (1) — (12,900 ) — — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — — (7,698 ) Other (2) — — — (584 ) — 690 106 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ — $ 1,768 $ 98,317 Cash contributions 1,112 — — — 104 2,499 3,715 Equity in income 22,900 — 2,336 1,199 — — 26,435 Equity in comprehensive income 248 — — — — — 248 Cash distributions received (5,864 ) — (2,400 ) (351 ) — — (8,615 ) Other — — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ — $ 5,916 $ 3,598 $ 104 $ 4,212 $ 120,045 Cash contributions 2,076 — — — 20,000 — 22,076 Equity in income (loss) 22,899 — 1,270 1,313 (82 ) — 25,400 Equity in comprehensive loss (139 ) — — — — — (139 ) Cash distributions received (5,799 ) — (1,920 ) (219 ) — — (7,938 ) Other (2) — — — (2,437 ) (104 ) (137 ) (2,678 ) Balance at December 31, 2018 $ 125,252 $ — $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 (1) RealD, Inc (2)
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP as of and for the years ended December 31, 2016, 2017 and 2018: Year ended December 31, 2016 2017 2018 Revenues $ 178,836 $ 177,382 $ 172,534 Operating income $ 107,919 $ 106,687 $ 102,236 Net income $ 89,152 $ 93,103 $ 94,757 As of December 31, 2017 December 31, 2018 Current assets $ 56,296 $ 57,907 Noncurrent assets $ 772,438 $ 684,545 Current liabilities $ 59,153 $ 67,408 Noncurrent liabilities $ 296,889 $ 125,596 Members' equity $ 472,692 $ 549,448
Transactions with DCIP	The Company had the following transactions with DCIP during the years ended December 31, 2016, 2017 and 2018: Year Ended December 31, 2016 2017 2018 Equipment lease payments $ 5,217 $ 5,743 $ 4,862 Warranty reimbursements from DCIP $ (6,091 ) $ (8,511 ) $ (10,800 ) Management services fees $ 825 $ 823 $ 730

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS - NET (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 Acquisitions of theatres (2) 9,878 13,211 23,089 Foreign currency translation adjustments — (1,973 ) (1,973 ) Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 Acquisitions of theatres (3) — 7,204 7,204 Foreign currency translation adjustments — (14,959 ) (14,959 ) Balance at December 31, 2018 (1) $ 1,174,041 $ 102,283 $ 1,276,324 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) (3) Amount represents preliminary purchase price allocation for theatres acquired in Brazil.
Intangible Assets	As of December 31, intangible assets-net, consisted of the following: Balance at Balance at January 1, December 31, 2017 Additions (1) Amortization Other (2) 2017 Intangible assets with finite lives: Gross carrying amount $ 99,796 $ 11,584 $ — $ (5,485 ) $ 105,895 Accumulated amortization (64,606 ) — (5,563 ) 1,300 (68,869 ) Total net intangible assets with finite lives $ 35,190 $ 11,584 $ (5,563 ) $ (4,185 ) $ 37,026 Intangible assets with indefinite lives: Tradename 299,709 — — 26 299,735 Total intangible assets — net $ 334,899 $ 11,584 $ (5,563 ) $ (4,159 ) $ 336,761 Balance at Balance at January 1, December 31, 2018 Additions (3) Amortization Other (2) 2018 Intangible assets with finite lives: Gross carrying amount $ 105,895 $ 1,203 $ — $ (1,842 ) $ 105,256 Accumulated amortization (68,869 ) — (5,734 ) — (74,603 ) Total net intangible assets with finite lives $ 37,026 $ 1,203 $ (5,734 ) $ (1,842 ) $ 30,653 Intangible assets with indefinite lives: Tradename and other 299,735 853 — (331 ) 300,257 Total intangible assets — net $ 336,761 $ 2,056 $ (5,734 ) $ (2,173 ) $ 330,910 (1) Activity for 2017 represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets. (2) Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments. (3) Amount for intangible assets with finite lives represents preliminary purchase price allocation for theatres acquired in Brazil.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows ( 1) For the year ended December 31, 2019 $ 4,785 For the year ended December 31, 2020 5,053 For the year ended December 31, 2021 2,904 For the year ended December 31, 2022 2,812 For the year ended December 31, 2023 3,161 Thereafter 11,938 Total $ 30,653

IMPAIRMENT OF LONG-LIVED ASSE_2

IMPAIRMENT OF LONG-LIVED ASSETS (Tables)	12 Months Ended
	Dec. 31, 2018
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Long-Lived Asset Impairment Charges	The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2016 2017 2018 U.S. theatre properties $ 1,929 $ 5,227 $ 18,597 International theatre properties 907 9,857 13,775 Impairment of long-lived assets $ 2,836 $ 15,084 $ 32,372

Deferred Charges and Other A_2

Deferred Charges and Other Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2018
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets Net	As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2017 2018 Long-term prepaid rents (1) $ 7,762 $ 15,943 Construction and other deposits 12,167 8,183 Equipment to be placed in service 13,868 10,466 Other 5,970 6,463 Total $ 39,767 $ 41,055 (1)

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Components of Long-Term Debt	As of December 31, long-term debt consisted of the following: December 31, 2017 2018 Cinemark USA, Inc. term loan $ 659,517 $ 652,922 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Other (1) 2,778 1,389 Total long-term debt 1,817,295 1,809,311 Less current portion 7,099 7,984 Less debt issuance costs, net of accumulated amortization of $25,549 and $30,289, respectively 29,815 28,700 Long-term debt, less current portion $ 1,780,381 $ 1,772,627 (1) Represents debt owed to NCM in relation to the joint venture AC JV, LLC. See Note 5.
Amendment of Credit Agreement	Cinemark USA, Inc. made the following amendments to its Credit Agreement as follows during 2016, 2017 and 2018: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 13, 2016 Reduced term loan interest rate by 0.25% $ 783 $ 249 December 15, 2016 Reduced term loan interest rate by 0.50% $ 2,446 $ 161 June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 March 29, 2018 Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements $ 4,962 $ 1,484 (1) Reflected as a reduction of long term debt on the consolidated balance sheet. (2) Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.
Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs	The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2018 matures as follows: 2019 $ 7,984 2020 6,595 2021 6,595 2022 406,595 2023 761,595 Thereafter 619,947 Total $ 1,809,311
Summary of Interest Rate Swap Agreements	Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2018: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2018 (1) $ 175,000 December 31, 2018 2.751% 1-Month LIBOR December 31, 2022 $ 1,983 $ 137,500 December 31, 2018 2.765% 1-Month LIBOR December 31, 2022 $ 1,624 $ 137,500 December 31, 2018 2.746% 1-Month LIBOR December 31, 2022 $ 1,486 Total $ 5,093 (1)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Summary of Liabilities Measured at Fair Value on Recurring Basis	Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2018: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities $ (5,093 ) $ — $ — $ (5,093 )
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2018 Beginning balance - January 1 $ — Interest rate swaps effective December 31, 2018 5,093 Ending balance - December 31 $ 5,093 (1) Represents interest rate swap liabilities. See Note 11 for further discussion.

FOREIGN CURRENCY TRANSLATION (T

FOREIGN CURRENCY TRANSLATION (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Companies International Subsidiaries	Below is a summary of the impact of translating the financial statements of all of the Company’s international subsidiaries as of and for the years ended December 31, 2016, 2017 and 2018. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2016 2017 2018 2016 2017 2018 Brazil 3.26 3.31 3.88 $ 37,286 $ (4,567 ) $ (34,086 ) Argentina (1) 16.04 18.65 37.68 (13,362 ) (8,200 ) (14,357 ) Colombia 3,000.71 2,936.67 3,249.75 1,278 246 (1,795 ) Chile 679.09 615.97 694.74 1,855 5,672 (8,924 ) Peru 3.45 3.24 3.39 87 2,752 (2,136 ) All other (783 ) (869 ) (955 ) $ 26,361 $ (4,966 ) $ (62,253 ) (1) Amount represents the cumulative comprehensive loss recorded for Argentina through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, beginning July 1, 2018, which was not significant, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statement of income.

NONCONTROLLING INTERESTS IN S_2

NONCONTROLLING INTERESTS IN SUBSIDIARIES (Tables)	12 Months Ended
	Dec. 31, 2018
Noncontrolling Interest [Abstract]
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2017 2018 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,795 $ 8,152 Laredo Theatres – 25% interest (in two theatres) 1,746 2,308 Greeley Ltd. — 49% interest (in one theatre) 843 1,411 Other 509 508 Total $ 11,893 $ 12,379
Summary of Impact of Changes in Company's Ownership Interest in its Subsidiaries on its Equity	Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2016 2017 2018 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 265,643 $ 215,735 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest (27 ) — — Net transfers from non-controlling interests (27 ) — — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 256,750 $ 265,643 $ 215,735

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2018
Summary of Restricted Stock Unit Financial Performance Thresholds and Vesting Rates	The financial performance factors and respective vesting rates for each of the 2016, 2017 and 2018 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2016 2017 2018 Threshold IRR 6.0% 7.0% 7.0% 33.3% Target IRR 8.0% 9.5% 9.5% 66.6% Maximum IRR 10.0% 13.0% 13.0% 100.0%
Number of Units Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2016, 2017 and 2018 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2016 2017 2018 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 84,554 $ 2,522 58,545 $ 2,481 76,065 $ 2,967 at target IRR 169,107 $ 5,044 117,089 $ 4,961 152,129 $ 5,938 at maximum IRR 253,661 $ 7,568 175,634 $ 7,442 228,194 $ 8,906 (1) The grant date fair values for units issued during the years ended December 31, 2016 and 2017 were $29.83 and $42.37, respectively. The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03.
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2016 2017 2018 Compensation expense recognized by the Company during the period $ 7,269 $ 7,528 $ 8,735 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 981 $ 856 $ 920 Fair value of restricted shares held by Company employees that vested during the period $ 13,739 $ 7,255 $ 8,699 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 923 $ 917 $ 802 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 5,167 $ 2,281 $ 1,543 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 388 $ 386 $ 201
Cinemark Holdings, Inc.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2016, 2017 and 2018: Year Ended Year Ended Year Ended December 31, 2016 December 31, 2017 December 31, 2018 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 757,775 $ 30.73 606,618 $ 33.51 650,581 $ 35.81 Granted 335,707 $ 30.98 246,534 $ 41.70 328,734 $ 38.72 Vested (430,056 ) $ 26.60 (192,230 ) $ 36.26 (250,442 ) $ 31.27 Forfeited (56,808 ) $ 33.81 (10,341 ) $ 33.48 (24,520 ) $ 38.62 Outstanding at December 31 606,618 $ 33.51 650,581 $ 35.81 704,353 $ 38.68
Cinemark Holdings, Inc. | Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2016 2017 2018 Number of restricted stock unit awards that vested during the period 213,984 97,115 127,084 Fair value of restricted stock unit awards that vested during the period $ 7,260 $ 4,155 $ 4,846 Accumulated dividends paid upon vesting of restricted stock unit awards $ 662 $ 558 $ 526 Compensation expense recognized during the period $ 5,144 $ 4,297 $ 4,681 Income tax benefit recognized upon vesting of restricted stock unit awards $ 3,049 $ 1,745 $ 708

SUPPLEMENTAL CASH FLOW INFORM_2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2016 2017 2018 Cash paid for interest $ 108,101 $ 99,232 $ 98,411 Cash paid for income taxes, net of refunds received $ 93,368 $ 95,043 $ 64,199 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ (29,471 ) $ 9,349 $ (5,728 ) Theatre properties acquired under capital lease $ 33,282 $ 46,727 $ 18,851 Investment in NCM – receipt of common units (see Note 4) $ 11,111 $ 18,363 $ 5,012 Interest expense - NCM (see Note 3) $ — $ — $ (19,724 ) (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2017 and 2018 were $31,276 and $37,004, respectively.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Before Income Taxes	The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2016 2017 2018 Income before income taxes: U.S. $ 277,474 $ 282,896 $ 292,238 Foreign 85,890 64,842 21,007 Total $ 363,364 $ 347,738 $ 313,245
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2016 2017 2018 Current: Federal $ 66,210 $ 55,224 $ 47,333 Foreign 32,047 29,306 11,822 State 12,061 10,741 13,690 Total current expense $ 110,318 $ 95,271 $ 72,845 Deferred: Federal $ (13,667 ) $ (14,046 ) $ 27,055 Foreign 1,674 (4,270 ) (6,166 ) State 6,526 3,301 2,298 Total deferred taxes $ (5,467 ) $ (15,015 ) $ 23,187 Income taxes $ 104,851 $ 80,256 $ 96,032
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2016 2017 2018 Computed statutory tax expense $ 127,176 $ 121,708 $ 65,781 Foreign inflation adjustments (281 ) — — State and local income taxes, net of federal income tax impact 12,081 12,857 12,686 Foreign losses not benefited and changes in valuation allowance (34,757 ) 249 822 Foreign tax rate differential (942 ) (245 ) 2,235 Foreign dividends 68,684 13,662 — Foreign tax credits (62,815 ) (21,647 ) 3,927 Impacts related to 2017 Tax Act (1)(2) — (44,889 ) 19,180 Changes in uncertain tax positions 921 983 (6,139 ) Other — net (5,216 ) (2,422 ) (2,460 ) Income taxes $ 104,851 $ 80,256 $ 96,032 (1) The year ended December 31, 2018 includes a one-time true-up of deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267. (2) The year ended December 31, 2017 includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2017 and 2018 consisted of the following: December 31, 2017 2018 Deferred liabilities: Theatre properties and equipment $ 147,208 $ 158,797 Intangible asset — other 30,770 33,561 Intangible asset — tradenames 72,967 73,261 Investment in partnerships 67,449 63,217 Total deferred liabilities 318,394 328,836 Deferred assets: Deferred lease expenses 14,714 13,464 Exchange loss 220 1,306 Deferred revenue - NCM 85,816 70,688 Capital lease obligations 67,369 63,895 Tax impact of items in accumulated other comprehensive income — 2,237 Other tax loss carryforwards 15,564 15,608 Other tax credit carryforwards 38,436 42,989 Other expenses, not currently deductible for tax purposes 13,801 26,776 Total deferred assets 235,920 236,963 Net deferred income tax liability before valuation allowance 82,474 91,873 Valuation allowance against deferred assets – non-current 35,246 54,725 Net deferred income tax liability $ 117,720 $ 146,598 Net deferred tax (asset) liability — Foreign $ 3,073 $ (5,449 ) Net deferred tax liability — U.S. 114,647 152,047 Total $ 117,720 $ 146,598
Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2016, 2017 and 2018: Year Ended December 31, 2016 2017 2018 Balance at January 1, $ 17,133 $ 17,403 $ 18,266 Gross increases - tax positions in prior periods 13 92 — Gross decreases - tax positions in prior periods — (12 ) (143 ) Gross increases - current period tax positions 923 265 424 Settlements (924 ) (177 ) (7,191 ) Foreign currency translation adjustments 258 695 (795 ) Balance at December 31, $ 17,403 $ 18,266 $ 10,561

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]
Rent Expenses from Operating Leases	Theatre rent expense was as follows: Year Ended December 31, 2016 2017 2018 Fixed rent expense $ 242,927 $ 247,908 $ 248,543 Contingent rent and other facility lease expenses 78,367 80,289 74,773 Total facility lease expense $ 321,294 $ 328,197 $ 323,316
Estimated Future Minimum Lease Payments (Net of Noncancelable Sublease Rentals) Under Capital Leases	Future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 are as follows (1) Operating Capital Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467 (1) Represents amounts before the adoption of ASC Topic 842 – Leases . See Note 2 for discussion of the expected impact of adoption.
Estimated Future Minimum Lease Payments (Net of Noncancelable Sublease Rentals) Under Operating Leases	Future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 are as follows (1) Operating Capital Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467 (1) Represents amounts before the adoption of ASC Topic 842 – Leases . See Note 2 for discussion of the expected impact of adoption.

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2016 2017 2018 Revenues U.S. $ 2,230,693 $ 2,236,237 $ 2,551,719 International 701,573 769,436 682,778 Eliminations (13,501 ) (14,126 ) (12,762 ) Total revenues $ 2,918,765 $ 2,991,547 $ 3,221,735 Adjusted EBITDA U.S. $ 550,150 $ 559,693 $ 650,189 International 157,690 165,576 132,941 Total Adjusted EBITDA $ 707,840 $ 725,269 $ 783,130 Capital expenditures U.S. $ 242,271 $ 321,040 $ 270,870 International 84,637 59,822 75,203 Total capital expenditures $ 326,908 $ 380,862 $ 346,073 (1) Distributions from equity investees are reported entirely within the U.S. operating segment.
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2016 2017 2018 Net income $ 258,513 $ 267,482 $ 217,213 Add (deduct): Income taxes 104,851 80,256 96,032 Interest expense (1) 108,313 105,918 109,994 Loss on debt amendments and refinancing 13,445 521 1,484 Other income (2) (44,813 ) (43,121 ) (18,450 ) Other cash distributions from equity investees (3) 21,916 25,973 30,143 Depreciation and amortization 209,071 237,513 261,162 Impairment of long-lived assets 2,836 15,084 32,372 Loss on disposal of assets and other 20,459 22,812 38,702 Deferred lease expenses (990 ) (1,268 ) (1,320 ) Amortization of long-term prepaid rents 1,826 2,274 2,382 Share based awards compensation expense $ 12,413 $ 11,825 $ 13,416 Adjusted EBITDA $ 707,840 $ 725,269 $ 783,130 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM. (3) Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.
Selected Financial Information by Geographic Area	Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2016 2017 2018 Revenues U.S. $ 2,230,693 $ 2,236,237 $ 2,551,719 Brazil 304,407 341,485 283,009 Other international countries 397,166 427,951 399,769 Eliminations (13,501 ) (14,126 ) (12,762 ) Total $ 2,918,765 $ 2,991,547 $ 3,221,735 December 31, 2017 December 31, 2018 Theatre Properties and Equipment-net U.S. $ 1,439,168 $ 1,479,603 Brazil 179,669 140,570 Other international countries 209,217 212,960 Total $ 1,828,054 $ 1,833,133

VALUATION AND QUALIFYING ACCO_2

VALUATION AND QUALIFYING ACCOUNTS (Tables)	12 Months Ended
	Dec. 31, 2018
Valuation And Qualifying Accounts [Abstract]
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2016, 2017 and 2018 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2016 $ 50,636 Additions 483 Deductions (36,595 ) Balance at December 31, 2016 $ 14,524 Additions 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 Additions ( 1 ) 22,005 Deductions (2,526 ) Balance at December 31, 2018 $ 54,725 (1) A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)	12 Months Ended
	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 Other current assets 59,661 17,841 76,789 (19,270 ) 135,021 Accounts receivable from parent or subsidiaries 117,972 119,616 — (223,007 ) 14,581 Total current assets 308,223 318,080 287,991 (242,277 ) 672,017 Theatre properties and equipment - net 650,783 765,500 411,771 — 1,828,054 Investment in subsidiaries 1,691,626 121,795 — (1,813,421 ) — Other assets 1,427,328 134,845 536,816 (113,720 ) 1,985,269 Total assets $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 Liabilities and equity Current liabilities Current portion of long-term debt $ 5,710 $ — $ 1,389 $ — $ 7,099 Current portion of capital lease obligations 9,532 11,124 4,855 — 25,511 Accounts payable and accrued expenses 215,580 116,409 110,089 (6,402 ) 435,676 Accounts payable to parent or subsidiaries — — 223,007 (223,007 ) — Total current liabilities 230,822 127,533 339,340 (229,409 ) 468,286 Long-term liabilities Long-term debt, less current portion 1,878,992 — 11,211 (109,822 ) 1,780,381 Capital lease obligations, less current portion 132,189 75,767 43,195 — 251,151 Other long-term liabilities and deferrals 426,355 60,567 93,871 (16,766 ) 564,027 Total long-term liabilities 2,437,536 136,334 148,277 (126,588 ) 2,595,559 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,360,059 618,985 726,830 (1,345,815 ) 1,360,059 Total Cinemark USA, Inc. stockholder's equity 1,409,602 1,076,353 737,068 (1,813,421 ) 1,409,602 Noncontrolling interests — — 11,893 — 11,893 Total equity 1,409,602 1,076,353 748,961 (1,813,421 ) 1,421,495 Total liabilities and equity $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) - Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) - Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 413,177 60,137 77,844 (6,137 ) 545,021 Total long-term liabilities 2,409,133 119,676 135,398 (114,092 ) 2,550,115 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,415,262 673,174 723,319 (1,396,494 ) 1,415,261 Total Cinemark USA, Inc. stockholder's equity 1,464,805 1,130,542 733,557 (1,864,100 ) 1,464,804 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,464,805 1,130,542 745,936 (1,864,100 ) 1,477,183 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on disposal of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on disposal of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,192,478 $ 1,362,043 $ 723,804 $ (56,590 ) $ 3,221,735 Cost of operations Theatre operating expenses 916,726 933,858 541,981 (56,590 ) 2,335,975 General and administrative expenses 11,497 100,407 50,736 — 162,640 Depreciation and amortization 89,429 99,627 72,106 — 261,162 Impairment of long-lived assets 4,118 13,612 14,642 — 32,372 Loss on disposal of assets and other 13,321 23,337 2,044 — 38,702 Total cost of operations 1,035,091 1,170,841 681,509 (56,590 ) 2,830,851 Operating income 157,387 191,202 42,295 - 390,884 Other income (expense) Interest expense (97,585 ) (6,520 ) (7,266 ) 1,377 (109,994 ) Loss on debt amendments and refinancing (1,484 ) — — — (1,484 ) Distributions from NCM — — 15,389 — 15,389 Interest expense - NCM (19,724 ) — — — (19,724 ) Equity in income of affiliates 183,463 (12,561 ) 33,167 (164,827 ) 39,242 Other income 4,287 (14 ) (3,964 ) (1,377 ) (1,068 ) Total other income 68,957 (19,095 ) 37,326 (164,827 ) (77,639 ) Income before income taxes 226,344 172,107 79,621 (164,827 ) 313,245 Income taxes 10,608 68,624 16,800 - 96,032 Net income 215,736 103,483 62,821 (164,827 ) 217,213 Less: Net income attributable to noncontrolling interests — — 1,478 — 1,478 Net income attributable to Cinemark USA, Inc. $ 215,736 $ 103,483 $ 61,343 $ (164,827 ) $ 215,735
Condensed Consolidating Statement of Comprehensive Income Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income, net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $138 234 — — — 234 Other comprehensive income of equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive income (loss), net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 215,736 $ 103,483 $ 62,821 $ (164,827 ) $ 217,213 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, net of settlements (3,851 ) — — — (3,851 ) Other comprehensive loss of equity method investments (139 ) — (139 ) 139 (139 ) Foreign currency translation adjustments (62,253 ) — (62,253 ) 62,253 (62,253 ) Total other comprehensive loss, net of tax (66,243 ) — (62,392 ) 62,392 (66,243 ) Total comprehensive income, net of tax $ 149,493 $ 103,483 $ 429 $ (102,435 ) $ 150,970 Comprehensive income attributable to noncontrolling interests — — (1,478 ) — (1,478 ) Comprehensive income attributable to Cinemark USA, Inc. $ 149,493 $ 103,483 $ (1,049 ) $ (102,435 ) $ 149,492
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (178,147 ) 55,128 53,381 301,946 232,308 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 232,715 102,817 126,727 — 462,259 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the U.S. (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Fees paid related to debt amendments (11,076 ) — — — (11,076 ) Intercompany loan proceeds — — 4,455 (4,455 ) - Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (140,426 ) (16,839 ) (257,083 ) 251,227 (163,121 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (122,559 ) 71,023 33,515 270,189 252,168 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash provided by operating activities 161,307 187,884 179,193 — 528,384 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) - (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash used for investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing Activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Fees paid related to debt amendments (521 ) — — — (521 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash provided by financing activities (148,436 ) (129,450 ) (9,016 ) 129,473 (157,429 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 215,736 $ 103,483 $ 62,821 $ (164,827 ) $ 217,213 Adjustments to reconcile net income to cash provided by operating activities (36,894 ) 162,811 55,915 164,827 346,659 Changes in assets and liabilities 229,325 (233,263 ) (3,635 ) — (7,573 ) Net cash provided by operating activities 408,167 33,031 115,101 — 556,299 Investing activities Additions to theatre properties and equipment (91,244 ) (173,042 ) (81,787 ) — (346,073 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 2,025 651 — 3,920 Proceeds from intercompany note repayments 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) 361 — (19,535 ) Net cash used for investing activities (166,526 ) (190,913 ) (92,064 ) (1,867 ) (451,370 ) Financing activities Dividends paid to parent (148,750 ) — — — (148,750 ) Repayments of long-term debt (7,984 ) — — — (7,984 ) Payment of debt issue costs (5,218 ) — — — (5,218 ) Payments on capital leases (11,610 ) (8,950 ) (4,793 ) — (25,353 ) Payments on intercompany loans — - (1,867 ) 1,867 — Other (704 ) (2,905 ) (992 ) — (4,601 ) Net cash used for financing activities (174,266 ) (11,855 ) (7,652 ) 1,867 (191,906 ) Effect of exchange rate changes on cash and cash equivalents — — (9,222 ) — (9,222 ) Increase (decrease) in cash and cash equivalents 67,375 (169,737 ) 6,163 — (96,199 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2018USD ($)SegmentUnit	Dec. 31, 2017USD ($)Segment	Dec. 31, 2016USD ($)Segment
Summary Of Significant Accounting Policies [Line Items]
Approximate remaining lease period for owned properties	20 years
Multiple of cash flows used to estimate fair value of long-lived asset	6.5	6.5	6.5
Number of domestic reporting units for which quantitative goodwill assessment performed | Unit	3
Goodwill impairment charges	$ 0	$ 0	$ 0
Requirements to be classified as capital lease, minimum amount of present value of future minimum lease payments against estimated fair value, percentage	90.00%
Requirements to be classified as capital lease, minimum length of lease term against estimated useful life, percentage	75.00%
General liability claim per occurrence, cap	$ 250,000	250,000	100,000
Aggregate annual cap per policy year	4,750,000	3,900,000	3,350,000
Annual cap for self-insured workers compensation plan	5,000,000	5,000,000
Medical claim per occurrence, cap	250,000	250,000	$ 150,000
Insurance Reserves	$ 10,827,000	$ 8,252,000
Minimum Percentage for Tax position measure as largest amount of benefit	50.00%
Reportable operating segments | Segment	2	2	2
Trade Names
Summary Of Significant Accounting Policies [Line Items]
Impairment of intangible assets	$ 0	$ 0	$ 0
U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment	20
Multiplication Value to Cash flows for the determination of fair value of Reporting units	8	8
International Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment	7
Minimum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	20.00%
Amortization period of deferred charges and other assets	1 year
Maximum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%
Amortization period of deferred charges and other assets	17 years
Pre-funding claims and covers claims per occurrence		$ 250,000

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
	Dec. 31, 2018
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	40 years
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings Under Capital and Finance Leases
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life	[1]
Theatre furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
[1]	Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital and finance lease assets as of December 31, 2017 and 2018 was $200,683 and $177,733, respectively.

Estimated Useful Lives of Ass_2

Estimated Useful Lives of Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 1,571,017	$ 1,500,535
Property Under Capital and Finance Lease
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 177,733	$ 200,683

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2018
Finite Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately two to eight years.
Tradename | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Tradename | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years
Vendor Contracts
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is two years.
Favorable/unfavorable leases
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately one to eighteen years. See Note 2 for discussion of the expected impact of new lease accounting pronouncements.
Favorable/unfavorable leases | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Favorable/unfavorable leases | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	18 years
Other Intangible Assets
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from two to eight years.
Other Intangible Assets | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Other Intangible Assets | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years

New Accounting Pronouncements -

New Accounting Pronouncements - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Corporate income tax rate percent	21.00%	35.00%
ASU 2016-02 | Subsequent Event | Minimum
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating leases, future minimum payments				$ 1,400,000
ASU 2016-02 | Subsequent Event | Maximum
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating leases, future minimum payments				$ 1,700,000
ASU 2016-15
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reclassification of cash payments recorded in loss on debt amendments and refinancing from operating activities to financing activities		$ 521	$ 11,076

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Jan. 01, 2018
Revenue Recognition [Line Items]
Cumulative effect of accounting change adjustment net of taxes, in retained earnings		$ 40,526,000
Receivables related to contracts with customers	$ 48,117,000
Assets related to costs to obtain or fulfill contract with customers	0
NCM
Revenue Recognition [Line Items]
Remaining performance obligations	$ 174,000,000
Deferred revenue amortization year and month	2037-02
Recognized incremental screen advertising revenue and offsetting interest expense	$ 19,724,000
NCM | Minimum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates	5.50%
NCM | Maximum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates	8.00%

Revenue Recognition - Summary o

Revenue Recognition - Summary of Impact Upon Adoption of ASC Topic 606 on Statements of Income and Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenue Recognition [Line Items]
Revenues	$ 3,221,735	$ 2,991,547	$ 2,918,765
Utilities and other expense	448,070	355,041	355,926
Statement of cash flows:
Amortization of deferred revenues, deferred lease incentives and other	(21,706)	(16,211)	(16,731)
Changes in other assets and liabilities - Other long-term liabilities	11,967	8,294	(5,076)
NCM
Revenue Recognition [Line Items]
Interest expense - NCM	19,724
Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Utilities and other expense	354,740
Statement of cash flows:
Amortization of deferred revenues, deferred lease incentives and other	(17,602)
Changes in other assets and liabilities - Other long-term liabilities	4,375
Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Utilities and other expense	93,330
Statement of cash flows:
Amortization of deferred revenues, deferred lease incentives and other	(4,104)
Changes in other assets and liabilities - Other long-term liabilities	7,592
Adoption of ASC Topic 606 | Impact of Adoption of ASC 606 | NCM
Revenue Recognition [Line Items]
Interest expense - NCM	19,724
Admissions Revenues
Revenue Recognition [Line Items]
Revenues	1,834,173	1,794,982	1,789,137
Admissions Revenues | Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	1,839,723
Admissions Revenues | Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	(5,550)
Concession Revenues
Revenue Recognition [Line Items]
Revenues	1,108,793	$ 1,038,788	$ 990,103
Concession Revenues | Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	1,110,703
Concession Revenues | Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	(1,910)
Other
Revenue Recognition [Line Items]
Revenues	278,769
Other | Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	161,743
Other | Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Revenues	$ 117,026

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Impact of Adoption of ASC 606 on Balance Sheet (Detail) - USD ($) $ in Thousands		Dec. 31, 2018		Dec. 31, 2017
Revenue Recognition [Line Items]
Long-term deferred tax liability		$ 155,626		$ 121,787
Other long-term liabilities		49,431		41,247
Retained earnings		480,580		373,069
Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Long-term deferred tax liability		142,547
Other long-term liabilities		41,839
Retained earnings		440,054
Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Long-term deferred tax liability		13,079
Other long-term liabilities		7,592
Retained earnings		40,526
NCM
Revenue Recognition [Line Items]
Deferred revenue - NCM		287,349	[1]	$ 351,706
NCM | Adoption of ASC Topic 606 | Without Adoption of ASC 606
Revenue Recognition [Line Items]
Deferred revenue - NCM	[1]	345,058
NCM | Adoption of ASC Topic 606 | Impact of Adoption of ASC 606
Revenue Recognition [Line Items]
Deferred revenue - NCM	[1]	$ (57,709)
[1]	Includes the cumulative effect of accounting change of $53,605 recorded on January 1, 2018 and the full year impact of the change in amortization method of $4,104 during the year ended December 31, 2018.

Revenue Recognition - Summary_3

Revenue Recognition - Summary of Impact of Adoption of ASC 606 on Balance Sheet (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Jan. 01, 2018
Revenue Recognition [Line Items]
Cumulative effect of accounting change adjustment net of taxes, in retained earnings		$ 40,526
Adoption of ASC Topic 606 | NCM
Revenue Recognition [Line Items]
Cumulative effect of accounting change adjustment net of taxes, in retained earnings		$ 53,605
Impact of change in amortization method	$ 4,104

Revenue Recognition - Summary_4

Revenue Recognition - Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disaggregation of Revenue [Line Items]
Total revenues		$ 3,221,735	$ 2,991,547	$ 2,918,765
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,538,957
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		682,778
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		1,834,173	1,794,982	1,789,137
Admissions Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	1,461,151
Admissions Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		373,022
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		1,108,793	$ 1,038,788	$ 990,103
Concession Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	892,391
Concession Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		216,402
Screen Advertising and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		139,860
Screen Advertising and Promotional Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	78,591
Screen Advertising and Promotional Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		61,269
Other Revenue
Disaggregation of Revenue [Line Items]
Total revenues		138,909
Other Revenue | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	106,824
Other Revenue | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 32,085
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations.

Revenue Recognition - Summary_5

Revenue Recognition - Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disaggregation of Revenue [Line Items]
Total revenues		$ 3,221,735	$ 2,991,547	$ 2,918,765
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,538,957
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		682,778
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		3,061,660
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,453,313
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		608,347
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		160,075
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	85,644
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 74,431
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations.

Revenue Recognition - Changes i

Revenue Recognition - Changes in Deferred Revenues (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018		$ 438,204
Amounts recognized as accounts receivable		6,921
Cash received from customers in advance		156,237
Common units received from NCM (see Note 6)		5,012
Revenue recognized during period		(156,940)
Foreign currency translation adjustments		(2,405)
Balance at December 31, 2018		393,424	$ 438,204
Adoption of ASC Topic 606
Change in Contract with Customer Liability [Line Items]
Impact of adoption of ASC Topic 606		(53,605)
Deferred Revenue
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 6)		(5,012)	(18,363)	$ (11,111)
Deferred Revenue | NCM
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018		351,706
Common units received from NCM (see Note 6)		5,012
Revenue recognized during period		(15,764)
Balance at December 31, 2018		287,349	351,706
Deferred Revenue | NCM | Adoption of ASC Topic 606
Change in Contract with Customer Liability [Line Items]
Impact of adoption of ASC Topic 606		(53,605)
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2018	[1]	86,498
Amounts recognized as accounts receivable	[1]	6,921
Cash received from customers in advance	[1]	156,237
Revenue recognized during period	[1]	(141,176)
Foreign currency translation adjustments	[1]	(2,405)
Balance at December 31, 2018	[1]	$ 106,075	$ 86,498
[1]	Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet.

Revenue Recognition - Aggregate

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 393,424
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 105,354
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 31,977
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 16,038
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 16,030
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Remaining performance obligations	$ 208,194
Deferred Revenue | NCM
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 287,349
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 15,831
Deferred Revenue | NCM | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Remaining performance obligations	$ 208,194
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 106,075
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2019-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 89,523
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 16,146
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 207
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligations	$ 199

Revenue Recognition - Aggrega_2

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail 1) $ in Thousands	Dec. 31, 2018USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 393,424
Deferred Revenue | NCM
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	287,349
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 106,075

Investment in National CineMe_3

Investment in National CineMedia LLC - Additional Information (Detail)	Jul. 05, 2018USD ($)$ / sharesshares	Feb. 13, 2007USD ($)	Dec. 31, 2018USD ($)$ / shares$ / Theatreshares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Jul. 04, 2018	Dec. 31, 2015USD ($)
Schedule Of Equity Method Investments [Line Items]
Access fees per patron | $ / Theatre			0.07
Increase in percentage of payment per theatre patron			8.00%
Duration of percentage increase in theatre access fees per patron			5 years
Payment per digital screen		$ 800,000	$ 1,368,000	$ 1,303,000	$ 1,241,000
Percentage of annual increase in payment per digital screen			5.00%
Minimum percentage of aggregate advertising revenue for payment of fees			12.00%
'Remaining term of exhibitor services agreement			2037-02
Interest in common units of NCM owned by Company			25.00%
Number of common units of NCM owned by Company | shares			39,518,644
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Estimated fair value of investment using NCMI's stock price			$ 256,081,000
NCMI stock price | $ / shares			$ 6.48
Investment in NCM			$ 275,592,000	200,550,000	189,995,000		$ 183,755,000
NCM
Schedule Of Equity Method Investments [Line Items]
Number of common units of NCM acquired by Company | shares	10,738,740
Value of common units in cash	$ 78,393,000
Common unit price per share | $ / shares	$ 7.30
Interest in common units of NCM owned by Company	25.00%					18.00%
Investment in NCM			275,592,000	200,550,000
Impairment of investments			0
NCM | Theatre Properties and Equipment
Schedule Of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising			$ 74,000	$ 102,000	$ 49,000

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 5,012	$ 18,363	$ 11,111
Annual Common Unit Adjustment
Schedule Of Equity Method Investments [Line Items]
Date Common Units Received	Mar. 29, 2018	Mar. 31, 2017	Mar. 31, 2016
Number of Common Units Received	908,042	1,487,218	753,598
Fair Value of Common Units Received	$ 5,012	$ 18,363	$ 11,111

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		Jul. 05, 2018	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2018
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment			$ 5,012
Equity in earnings			39,242		$ 35,985	$ 31,962
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			200,550
Purchase of additional common units		$ 78,393
Purchase of additional common units			78,393
Ending Balance			275,592		200,550
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			200,550		189,995	183,755
Receipt of common units due to annual common unit adjustment			5,012		18,363	11,111
Purchase of additional common units			78,393
Receipt of excess cash distributions			(19,786)		(15,093)	(11,233)
Receipt under tax receivable agreement			(2,419)		(2,265)	(2,985)
Equity in earnings			13,842		9,550	9,347
Ending Balance			275,592		200,550	189,995
Deferred Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(351,706)		(343,928)	(342,134)
Impact of adoption of ASC Topic 606	[1]						$ 53,605
Receipt of common units due to annual common unit adjustment			(5,012)		(18,363)	(11,111)
Ending Balance			(287,349)		(351,706)	(343,928)
Deferred Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment			5,012
Amortization of deferred revenue			15,764	[1]	10,585	9,317
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(16,407)		(14,656)
Receipt of excess cash distributions			(13,231)		(14,158)	(11,483)
Receipt under tax receivable agreement			(2,158)		(2,249)	(3,173)
Ending Balance			(15,389)		(16,407)	(14,656)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(9,550)		(9,347)
Ending Balance			(13,842)		(9,550)	(9,347)
Equity in Earnings | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings			(13,842)		(9,550)	(9,347)
Other Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(21,859)		(20,365)
Revenues earned under ESA	[2]		(31,867)	[3]	(11,274)	(11,048)
Ending Balance			(47,631)		(21,859)	(20,365)
Other Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of deferred revenue			(15,764)	[1]	(10,585)	(9,317)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	[2],[3]		19,724
Ending Balance	[3]		19,724
Cash Received (Paid)
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			45,039		39,922
Revenues earned under ESA	[2]		12,143	[3]	11,274	11,048
Receipt of excess cash distributions			33,017		29,251	22,716
Receipt under tax receivable agreement			4,577		4,514	6,158
Ending Balance			$ 49,737		$ 45,039	$ 39,922
[1]	As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. The Company recorded a reduction in the deferred revenue balance and a cumulative effect of a change in accounting principle in retained earnings. See Note 3 for further discussion of the impact of the adoption of ASC Topic 606.
[2]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $10,523, $11,110 and $11,965 for the years ended December 31, 2016, 2017 and 2018, respectively.
[3]	Reflects the impact of significant financing component related to amounts received in advance under the ESA and CUA agreement. See Note 3.

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Equity Method Investments And Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 11,965	$ 11,110	$ 10,523

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	12 Months Ended
	Dec. 27, 2018	Dec. 28, 2017	Dec. 29, 2016
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 441,400	$ 426,100	$ 447,600
Operating income	154,300	153,900	173,000
Net income	98,400	101,900	$ 109,300
Current assets	172,700	174,400
Noncurrent assets	726,800	758,300
Current liabilities	115,200	123,300
Noncurrent liabilities	924,900	925,400
Members' deficit	$ (140,600)	$ (116,000)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Dec. 31, 2013	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			$ 120,045
Equity in income (loss)			39,242		$ 35,985	$ 31,962
Cash distributions received	[1]		(30,143)		(25,973)	(21,916)
Investments, ending balance			156,766		120,045
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Cash contributions		$ 268
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			120,045		98,317	94,973
Cash contributions			22,076		3,715	1,132
Equity in income (loss)			25,400		26,435	22,615
Equity in comprehensive income (loss)			(139)		248	89
Sale of investment	[2]					(12,900)
Cash distributions received			(7,938)		(8,615)	(7,698)
Other			(2,678)	[3]	(55)	106	[3]
Investments, ending balance			156,766		120,045	98,317
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			106,215		87,819	71,579
Cash contributions			2,076		1,112	717
Equity in income (loss)			22,899		22,900	21,434
Equity in comprehensive income (loss)			(139)		248	89
Sale of investment	[2]					0
Cash distributions received			(5,799)		(5,864)	(6,000)
Other			0	[3]	0	0	[3]
Investments, ending balance			125,252		106,215	87,819
Other Affiliates | RealD
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			0		0	12,900
Cash contributions			0		0	0
Equity in income (loss)			0		0	0
Equity in comprehensive income (loss)			0		0	0
Sale of investment	[2]					(12,900)
Cash distributions received			0		0	0
Other			0	[3]	0	0	[3]
Investments, ending balance			0		0	0
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			5,916		5,980	7,269
Cash contributions			0		0	0
Equity in income (loss)			1,270		2,336	311
Equity in comprehensive income (loss)			0		0	0
Sale of investment	[2]					0
Cash distributions received			(1,920)		(2,400)	(1,600)
Other			0	[3]	0	0	[3]
Investments, ending balance			5,266		5,916	5,980
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			3,598		2,750	2,562
Cash contributions			0		0	0
Equity in income (loss)			1,313		1,199	870
Equity in comprehensive income (loss)			0		0	0
Sale of investment	[2]					0
Cash distributions received			(219)		(351)	(98)
Other			(2,437)	[3]	0	(584)	[3]
Investments, ending balance			2,255		3,598	2,750
Other Affiliates | FE Concepts
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			104		0	0
Cash contributions			20,000		104	0
Equity in income (loss)			(82)		0	0
Equity in comprehensive income (loss)			0		0	0
Sale of investment	[2]					0
Cash distributions received			0		0	0
Other			(104)	[3]	0	0	[3]
Investments, ending balance			19,918		104	0
Other Affiliates | Other Investment
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			4,212		1,768	663
Cash contributions			0		2,499	415
Equity in income (loss)			0		0	0
Equity in comprehensive income (loss)			0		0	0
Sale of investment	[2]					0
Cash distributions received			0		0	0
Other			(137)	[3]	(55)	690	[3]
Investments, ending balance			$ 4,075		$ 4,212	$ 1,768
[1]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.
[2]	See further discussion of the sale of the investment held by the Company under RealD, Inc. below.
[3]	Other activity for DCDC for the years ended December 31, 2016 and 2018 consisted of returns of capital originally contributed by the Company.

Other Investments - Additional

Other Investments - Additional Information (Detail)	Mar. 22, 2016USD ($)$ / shares	Dec. 31, 2013USD ($)	Mar. 31, 2011$ / shares	Dec. 31, 2018USD ($)RenewalOptionProjectionSystemshares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2011shares	Apr. 30, 2018USD ($)
Schedule Of Equity Method Investments [Line Items]
Number of options to purchase common stock | shares								1,222,780
Exercise price of options, shares | $ / shares			$ 0.00667
Proceeds from sale of marketable securities						$ 13,451,000
Number of shares owned in RealD | shares				1,222,780
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Cash contributions				$ 22,076,000	$ 3,715,000	1,132,000
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest				33.00%
Economic interest in Digital Cinema Implementation Partners				24.30%
Number of equipment being leased under master equipment lease agreement | ProjectionSystem				3,837
Digital Cinema Implementation Partners | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Digital projection systems leased under operating lease, initial term				12 years
Number of one-year fair value renewal options | RenewalOption				10
Minimum annual rent per digital projection system				$ 1,000
Cash contributions				2,076,000	1,112,000	717,000
RealD | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Purchase price per share | $ / shares	$ 11
Proceeds from sale of marketable securities	$ 13,451,000
Gain on investment						3,742,000
Unrealized holding gain previously recorded in AOCI						3,191,000
Cash contributions				0	0	0
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Cash contributions		$ 268,000
Ownership of class A units		32.00%
Promissory note term							6 years
Original principal value of promissory note with NCM							$ 8,333,000
Annual interest rate on promissory note		5.00%					5.00%
Remaining outstanding balance of note payable					1,389,000
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees				12,481,000	13,950,000	10,871,000
AC JV, LLC | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Cash contributions				$ 0	0	0
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest				14.60%
Payments for content delivery services				$ 927,000	848,000	939,000
Digital Cinema Distribution Coalition | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Cash contributions				$ 0	$ 0	$ 0
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest									50.00%
Investment in joint venture									$ 20,000,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest									50.00%
Investment in joint venture									$ 20,000,000

Summary Financial Information_2

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 172,534	$ 177,382	$ 178,836
Operating income	102,236	106,687	107,919
Net income	94,757	93,103	$ 89,152
Current assets	57,907	56,296
Noncurrent assets	684,545	772,438
Current liabilities	67,408	59,153
Noncurrent liabilities	125,596	296,889
Members' equity	$ 549,448	$ 472,692

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	$ 4,862	$ 5,743	$ 5,217
Warranty reimbursements from DCIP	(10,800)	(8,511)	(6,091)
Management services fees	$ 730	$ 823	$ 825

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,284,079		$ 1,262,963
Acquisitions of theatres		7,204	[2]	23,089	[3]
Foreign currency translation adjustments		(14,959)		(1,973)
Ending Balance	[1]	1,276,324		1,284,079
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,174,041		1,164,163
Acquisitions of theatres	[3]			9,878
Ending Balance	[1]	1,174,041		1,174,041
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	110,038		98,800
Acquisitions of theatres		7,204	[2]	13,211	[3]
Foreign currency translation adjustments		(14,959)		(1,973)
Ending Balance	[1]	$ 102,283		$ 110,038
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Amount represents preliminary purchase price allocation for theatres acquired in Brazil.
[3]	Acquisition of theatres in the U.S. and international markets.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2018USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Intangible Assets - Net (Detail

Intangible Assets - Net (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018		Dec. 31, 2017
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible assets with finite lives, Beginning balance		$ 105,895		$ 99,796
Other, Gross carrying amount	[1]	(1,842)		(5,485)
Intangible assets with finite lives, Ending balance		105,256		105,895
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(68,869)		(64,606)
Accumulated amortization additions		0	[2]	0	[3]
Accumulated amortization		(5,734)		(5,563)
Other Accumulated Amortization of Intangible Assets	[1]	0		1,300
Intangible assets with finite lives, Accumulated amortization, Ending balance		(74,603)		(68,869)
Net intangible assets with finite lives, Beginning balance		37,026		35,190
Intangible assets with finite lives, additions		1,203	[2]	11,584	[3]
Amortization, intangible assets		(5,734)		(5,563)
Other, Finite lived intangible assets	[1]	(1,842)		(4,185)
Net intangible assets with finite lives, Ending balance		30,653	[4]	37,026
Indefinite-lived Intangible Assets, Tradename, Beginning Balance		299,735		299,709
Indefinite-lived Intangible Assets, Tradename and other, Beginning Balance		299,735
Indefinite lived intangible assets, Tradename, additions	[3]			0
Indefinite lived intangible assets, Tradename and other, additions	[2]	853
Other, Tradename and other	[1]	(331)		26
Indefinite-lived Intangible Assets, Tradename, Ending Balance				299,735
Indefinite-lived Intangible Assets, Tradename and other, Ending Balance		300,257		299,735
Total intangible assets - net, Beginning balance		336,761		334,899
Other, Total intangible assets - net	[1]	(2,173)		(4,159)
Total intangible assets - net, Ending balance		$ 330,910		$ 336,761
[1]	Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments.
[2]	Amount for intangible assets with finite lives represents preliminary purchase price allocation for theatres acquired in Brazil
[3]	Activity for 2017 represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets.
[4]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands		Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016
Finite Lived Intangible Assets Net [Abstract]
For the year ended December 31, 2019	[1]	$ 4,785
For the year ended December 31, 2020	[1]	5,053
For the year ended December 31, 2021	[1]	2,904
For the year ended December 31, 2022	[1]	2,812
For the year ended December 31, 2023	[1]	3,161
Thereafter	[1]	11,938
Total		$ 30,653	[1]	$ 37,026	$ 35,190
[1]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 32,372	$ 15,084	$ 2,836
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	18,597	5,227	1,929
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	$ 13,775	$ 9,857	$ 907

Impairment of Long-Lived Asse_3

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 16,295

Deferred Changes and Other Asse

Deferred Changes and Other Assets (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Dec. 31, 2017
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Long-term prepaid rents	[1]	$ 15,943	$ 7,762
Construction and other deposits		8,183	12,167
Equipment to be placed in service		10,466	13,868
Other		6,463	5,970
Total		$ 41,055	$ 39,767
[1]	See Note 2 for discussion of the expected impact of the adoption of new lease accounting pronouncements.

Long Term Debt (Detail)

Long Term Debt (Detail) - USD ($) $ in Thousands		Dec. 31, 2018	Mar. 29, 2018	[2]	Dec. 31, 2017	Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan		$ 652,922			$ 659,517
Other	[1]	1,389			2,778
Total		1,809,311			1,817,295
Less current portion		7,984			7,099
Less debt issuance costs, net of accumulated amortization of $25,549 and $30,289, respectively		28,700	$ 4,962		29,815	$ 330		$ 521		$ 2,446		$ 783
Long-term debt, less current portion		1,772,627			1,780,381
5.125% senior notes due 2022
Debt Instrument [Line Items]
Senior notes		400,000			400,000
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Senior notes		$ 755,000			$ 755,000
[1]	Represents debt owed to NCM in relation to the joint venture AC JV, LLC. See Note 5.
[2]	Reflected as a reduction of long term debt on the consolidated balance sheet.

Long Term Debt (Parenthetical)

Long Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Disclosure [Abstract]
Debt issue costs, accumulated amortization	$ 30,289	$ 25,549

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Detail)

Mar. 30, 2018

Mar. 29, 2018USD ($)

Nov. 28, 2017USD ($)

Jun. 16, 2017USD ($)

Dec. 15, 2016USD ($)

Jun. 13, 2016USD ($)

Mar. 21, 2016USD ($)

May 24, 2013USD ($)

Dec. 18, 2012USD ($)

Jun. 03, 2011USD ($)

Dec. 31, 2018USD ($)Agreement

Dec. 31, 2017USD ($)

Dec. 31, 2016USD ($)

Dec. 31, 2012

Debt Instrument [Line Items]

Amount outstanding under the term loan

$ 652,922,000

$ 659,517,000

Percentage voting stock of foreign subsidiaries

65.00%

Multiple consolidated interest expense under sub condition two of condition two under dividend restriction

1.75

Debt issuance costs

$ 4,962,000

[1]

$ 330,000

[1]

$ 521,000

[1]

$ 2,446,000

[1]

$ 783,000

[1]

$ 28,700,000

29,815,000

Loss on debt amendments and refinancing

1,484,000

[2]

$ 331,000

[2]

$ 190,000

[2]

$ 161,000

[2]

$ 249,000

[2]

1,484,000

521,000

$ 13,445,000

Carrying value of long-term debt

1,809,311,000

1,817,295,000

Fair value of long-term debt

$ 1,774,066,000

1,840,918,000

Number of interest rate swap agreements | Agreement

3

Deferred taxes

$ 1,243,000

0

138,000

Designated as Hedging Instrument | Cash Flow Hedging

Debt Instrument [Line Items]

Estimated fair value

[3]

5,093,000

Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swaps

Debt Instrument [Line Items]

Estimated fair value

5,093,000

Deferred taxes

$ 1,243,000

Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Quarterly principal payments due

$ 1,649,000

Last quarterly payment date

Dec. 31, 2024

Final principal payment

$ 613,351,000

Actual coverage ratio

290.00%

Amended senior secured credit facility, dividend that could have distributed

$ 2,918,142,000

Amended Senior Secured Credit Facility | Maximum

Debt Instrument [Line Items]

Debt covenants, required minimum coverage ratio

500.00%

4.875 % Senior Notes Due May 2023

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 530,000,000

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

630.00%

Interest rate

4.875%

Debt instrument, maturity date

Jun. 1, 2023

Senior notes indenture, amount that could have distributed

$ 2,980,550,000

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

4.875 % Senior Notes Due June 1, 2023

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 225,000,000

$ 755,000,000

Interest rate

4.875%

4.875%

Debt instrument, maturity date

Jun. 1, 2023

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

99.00%

Debt issuance costs

$ 3,702,000

3,702,000

Debt issue costs, discount

2,250,000

2,250,000

7.375% senior subordinated notes due 2021

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 200,000,000

$ 200,000,000

Interest rate

7.375%

7.375%

Debt instrument, maturity period

2,021

2,021

Percentage of debt repayment premium

104.00%

Write off of unamortization of debt issuance cost

$ 2,369,000

Early retirement of debt

$ 9,444,000

Loss on debt amendments and refinancing

$ 1,222,000

5.125% senior notes due 2022

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 400,000,000

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

630.00%

Interest rate

5.125%

Debt instrument, maturity date

Dec. 15, 2022

Debt instrument, maturity period

2,022

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

Description of debt Instrument frequency of periodic payment

Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year.

Senior notes indenture, amount that could have distributed

$ 2,985,833,000

Term Loan Credit facility | Senior Secured Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

700,000,000

Term Loan Credit facility | Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Final principal payment due date

Mar. 29, 2025

Percentage of Variable rate added to federal funds effective rate

0.50%

Percentage of variable margin rate added to one-month Eurodollar rate

1.00%

Percentage of variable margin rate added to Eurodollar rate

1.75%

Debt instrument description of interest

a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum.

Amount outstanding under the term loan

$ 652,922,000

Average interest rate on outstanding borrowings

4.40%

Term Loan Credit facility | Amended Senior Secured Credit Facility | One Month Eurodollar Rate

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

0.75%

Revolving Credit Line | Senior Secured Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 100,000,000

Revolving Credit Line | Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Percentage of Variable rate added to federal funds effective rate

0.50%

Percentage of variable margin rate added to one-month Eurodollar rate

1.00%

Debt instrument description of interest

a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum.

Amount outstanding under the revolving credit line

0

$ 0

Available borrowing capacity

$ 98,846,000

Revolving Credit Line | Amended Senior Secured Credit Facility | Minimum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

1.50%

Revolving Credit Line | Amended Senior Secured Credit Facility | Maximum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

2.25%

Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Minimum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

0.50%

Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Maximum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

1.25%

[1]

Reflected as a reduction of long term debt on the consolidated balance sheet.

[2]

Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

[3]

Included in other long-term liabilities on the consolidated balance sheet as of December 31, 2018.

Long Term Debt - Amendment of C

Long Term Debt - Amendment of Credit Agreement (Detail) - USD ($) $ in Thousands

Mar. 29, 2018

Nov. 28, 2017

Jun. 16, 2017

Dec. 15, 2016

Jun. 13, 2016

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Debt Instrument [Line Items]

Debt Issue Cost Paid

$ 4,962

[1]

$ 330

[1]

$ 521

[1]

$ 2,446

[1]

$ 783

[1]

$ 28,700

$ 29,815

Loss on Debt Amendment

$ 1,484

[2]

$ 331

[2]

$ 190

[2]

$ 161

[2]

$ 249

[2]

$ 1,484

$ 521

$ 13,445

Amended Credit Agreement June 13, 2016

Debt Instrument [Line Items]

Nature of Amendment

Reduced term loan interest rate by 0.25%

Amended Credit Agreement December 15, 2016

Debt Instrument [Line Items]

Nature of Amendment

Reduced term loan interest rate by 0.50%

Amended Credit Agreement June 16, 2017

Debt Instrument [Line Items]

Nature of Amendment

Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement

Amended Credit Agreement November 28, 2017

Debt Instrument [Line Items]

Nature of Amendment

Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line

Amended Credit Agreement March 29, 2018

Debt Instrument [Line Items]

Nature of Amendment

Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements

[1]

Reflected as a reduction of long term debt on the consolidated balance sheet.

[2]

Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Long Term Debt - Amendment of_2

Long Term Debt - Amendment of Credit Agreement (Parenthetical) (Detail)	Mar. 29, 2018	Nov. 28, 2017	Jun. 16, 2017	Dec. 15, 2016	Jun. 13, 2016
Debt Disclosure [Abstract]
Debt instrument, reduction in interest rate	0.25%		0.25%	0.50%	0.25%
Debt instrument, extended maturity date	2025-03	2022-12

Maturities of Long-Term Debt, E

Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Disclosure [Abstract]
2,019	$ 7,984
2,020	6,595
2,021	6,595
2,022	406,595
2,023	761,595
Thereafter	619,947
Total	$ 1,809,311	$ 1,817,295

Long Term Debt - Summary of Int

Long Term Debt - Summary of Interest Rate Swap Agreements (Detail) - Cash Flow Hedging - Designated as Hedging Instrument $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 5,093	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.751%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 1,983	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.765%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 1,624	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.746%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 1,486	[1]
[1]	Included in other long-term liabilities on the consolidated balance sheet as of December 31, 2018.

Summary of Liabilities Measured

Summary of Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value on Recurring Basis $ in Thousands	Dec. 31, 2018USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ (5,093)
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ (5,093)

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) - Interest Rate Swaps $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)	[1]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Interest rate swaps effective December 31, 2018	$ 5,093
Ending balance - December 31	$ 5,093
[1]	Represents interest rate swap liabilities. See Note 11 for further discussion.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Fair value of assets transfers in or out, level 1 to level 2	$ 0	$ 0	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0	0	0
Fair value, asset transfers into Level 3	0	0	0
Fair value, asset transfers out of Level 3	$ 0	$ 0	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ 319,007	$ 253,282
Cumulative foreign currency adjustments	$ 315,300	253,565
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years
Reclassification of cumulative foreign currency translation adjustments	$ 518	(1,551)
Canada
Foreign Currency Translation [Line Items]
Reclassification of cumulative foreign currency translation adjustments		$ 1,551

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands		12 Months Ended
		Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)		$ (62,253)	$ (4,966)	$ 26,394
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate		3.88	3.31	3.26
Other comprehensive Income (Loss)		$ (34,086)	$ (4,567)	$ 37,286
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	[1]	37.68	18.65	16.04
Other comprehensive Income (Loss)	[1]	$ (14,357)	$ (8,200)	$ (13,362)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate		3,249.75	2,936.67	3,000.71
Other comprehensive Income (Loss)		$ (1,795)	$ 246	$ 1,278
Chile
Foreign Currency Translation [Line Items]
Exchange Rate		694.74	615.97	679.09
Other comprehensive Income (Loss)		$ (8,924)	$ 5,672	$ 1,855
Peru
Foreign Currency Translation [Line Items]
Exchange Rate		3.39	3.24	3.45
Other comprehensive Income (Loss)		$ (2,136)	$ 2,752	$ 87
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)		(955)	(869)	(783)
International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)		$ (62,253)	$ (4,966)	$ 26,361
[1]	Amount represents the cumulative comprehensive loss recorded for Argentina through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, beginning July 1, 2018, which was not significant, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statement of income.

Non-controlling Interest in Sub

Non-controlling Interest in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 12,379	$ 11,893
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	8,152	8,795
Laredo Theatre
Noncontrolling Interest [Line Items]
Noncontrolling interests	2,308	1,746
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,411	843
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 508	$ 509

Non-controlling Interest in S_2

Non-controlling Interest in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2018	Dec. 31, 2017
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	24.60%	24.60%
Laredo Theatre
Noncontrolling Interest [Line Items]
Ownership share	25.00%	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%	49.00%

Noncontrolling Interests in S_3

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2018	Dec. 31, 2017
Noncontrolling Interest [Line Items]
Percentage of remaining share purchased	25.00%
Purchase of noncontrolling interest	$ 450
Decrease in additional paid-in-capital		$ 450
Noncontrolling interests			$ 12,379	$ 11,893
Ownership percentage	100.00%	100.00%
Flix Impirica S.A.
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 423	$ 423
Cinemark USA, Inc. Stockholder's Equity
Noncontrolling Interest [Line Items]
Decrease in additional paid-in-capital	$ 27	$ 27

Summary of Impact of Changes in

Summary of Impact of Changes in Company's Ownership Interest in Subsidiary (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Noncontrolling Interest [Line Items]
Net income attributable to Cinemark USA, Inc.	$ 215,735	$ 265,643	$ 256,777
Net transfers from non-controlling interests		0	(27)
Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests	$ 215,735	265,643	256,750
Chile
Noncontrolling Interest [Line Items]
Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest		$ 0	$ (27)

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Restricted Stock
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 15,174
Remaining Compensation Expense recognition period (in years)	2 years
Restricted Stock | Cinemark USA, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 14,758
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Shares of restricted stock, granted	328,734	246,534	335,707
Market value of common stock on the dates of grant	$ 38.72	$ 41.70	$ 30.98
Unrecognized compensation expense	$ 416
Restricted Stock | Directors
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	0.00%
Restricted Stock | Minimum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 35.80
Restricted Stock | Minimum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	10.00%
Restricted Stock | Maximum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 39.26
Restricted Stock | Maximum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 42.37	$ 29.83
Unrecognized compensation expense	$ 8,416
Remaining Compensation Expense recognition period (in years)	2 years
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement).
Share-based compensation arrangement by share-based payment award, vesting condition	All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of common stock if the participant continues to provide services through the fourth anniversary of the grant date.
Internal rate of return, performance period	2 years
Percentage of IRR expected	9.00%
Expected forfeiture rate	5.00%
Number of hypothetical shares of common stock at maximum IRR level	594,266
Actual cumulative forfeitures (in units)	18,667
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Achieved Percentage of IRR	7.20%
Restricted Stock Units (RSUs) | Stock Grants 2017
Stockholders Equity Note [Line Items]
Estimated Percentage of IRR	11.20%
Restricted Stock Units (RSUs) | Stock Grants 2018
Stockholders Equity Note [Line Items]
Estimated Percentage of IRR	9.50%
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Number of hypothetical shares of common stock	228,194	175,634	253,661
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc. | Stock Grants 2013 and 2014
Stockholders Equity Note [Line Items]
Stock price at the date of modification			$ 37.98
Incremental compensation expense			$ 562
Restricted Stock Units (RSUs) | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 37.55
Restricted Stock Units (RSUs) | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 39.03
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - Cinemark Holdings, Inc. - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	650,581	606,618	757,775
Shares of Restricted Stock, Granted	328,734	246,534	335,707
Shares of Restricted Stock, Vested	(250,442)	(192,230)	(430,056)
Shares of Restricted Stock, Forfeited	(24,520)	(10,341)	(56,808)
Shares of Restricted Stock, Ending balance	704,353	650,581	606,618
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 35.81	$ 33.51	$ 30.73
Weighted Average Grant Date Fair Value, Granted	38.72	41.70	30.98
Weighted Average Grant Date Fair Value, Vested	31.27	36.26	26.60
Weighted Average Grant Date Fair Value, Forfeited	38.62	33.48	33.81
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 38.68	$ 35.81	$ 33.51

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	$ 8,735	$ 7,528	$ 7,269
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	8,699	7,255	13,739
Income tax benefit recognized upon vesting of share based awards	$ 1,543	$ 2,281	$ 5,167
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	250,442	192,230	430,056
Compensation expense recognized during the period	$ 920	$ 856	$ 981
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	802	917	923
Income tax benefit recognized upon vesting of share based awards	$ 201	$ 386	$ 388
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	127,084	97,115	213,984
Fair value of restricted shares that vested during the period	$ 4,846	$ 4,155	$ 7,260
Accumulated dividends paid upon vesting of restricted stock unit awards	526	558	662
Income tax benefit recognized upon vesting of share based awards	708	1,745	3,049
Compensation expense recognized during the period	$ 4,681	$ 4,297	$ 5,144

Summary of Financial Performanc

Summary of Financial Performance Thresholds and Vesting Rates (Detail) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold IRR	7.00%	7.00%	6.00%
Target IRR	9.50%	9.50%	8.00%
Maximum IRR	13.00%	13.00%	10.00%
Threshold IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	33.30%
Targeted IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	66.60%
Maximum IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	100.00%

Summary of Potential Number of

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Disclosure Of Restricted Stock Unit [Abstract]
Number of units at threshold IRR		76,065	58,545	84,554
Number of units at target IRR		152,129	117,089	169,107
Number of units at maximum IRR		228,194	175,634	253,661
Fair value of units at threshold IRR	[1]	$ 2,967	$ 2,481	$ 2,522
Fair value of units at target IRR	[1]	5,938	4,961	5,044
Fair value of units at maximum IRR	[1]	$ 8,906	$ 7,442	$ 7,568
[1]	The grant date fair values for units issued during the years ended December 31, 2016 and 2017 were $29.83 and $42.37, respectively. The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03.

Summary of Potential Number o_2

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Parenthetical) (Detail) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted		$ 42.37	$ 29.83
Minimum
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted	$ 37.55
Maximum
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted	$ 39.03

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest		$ 98,411	$ 99,232	$ 108,101
Cash paid for income taxes, net of refunds received		64,199	95,043	93,368
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]	(5,728)	9,349	(29,471)
Theatre properties acquired under capital lease		18,851	46,727	33,282
Investment in NCM – receipt of common units (see Note 4)		5,012	$ 18,363	$ 11,111
NCM
Noncash investing and financing activities:
Interest expense - NCM (see Note 3)		$ (19,724)
[1]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2017 and 2018 were $31,276 and $37,004, respectively.

Supplemental Information to C_2

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 37,004	$ 31,276

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Line Items]
Corporate income tax rate	21.00%	35.00%
Net additional non-cash provisional income tax expenses	$ 19,180
Accumulated undistributed earnings and profits	415,323
One-time transition tax accumulated undistributed earnings and profits	373,768
Valuation allowance against deferred assets – non-current	54,725	$ 35,246
Gross unrecognized tax benefits, including interest and penalties	13,953	20,231
Unrecognized tax benefit that if recognized would impact effective tax rate	13,953	20,231
Accrued for interest and penalties	3,390	5,288
Tax benefit	(96,032)	$ (80,256)	$ (104,851)
Chile
Income Taxes [Line Items]
Tax benefit	$ 6,802
Foreign | Minimum
Income Taxes [Line Items]
Tax credit carryforwards expiring year	2,023
State | Minimum
Income Taxes [Line Items]
Net operating losses carried forward expiring period	5 years
State | Maximum
Income Taxes [Line Items]
Net operating losses carried forward expiring period	20 years
Net operating losses carried forward expiring year	2,037

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income before income taxes, U.S.	$ 292,238	$ 282,896	$ 277,474
Income before income taxes, Foreign	21,007	64,842	85,890
Income before income taxes	$ 313,245	$ 347,738	$ 363,364

Current and Deferred Income Tax

Current and Deferred Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Current:
Federal	$ 47,333	$ 55,224	$ 66,210
Foreign	11,822	29,306	32,047
State	13,690	10,741	12,061
Total current expense	72,845	95,271	110,318
Deferred:
Federal	27,055	(14,046)	(13,667)
Foreign	(6,166)	(4,270)	1,674
State	2,298	3,301	6,526
Total deferred taxes	23,187	(15,015)	(5,467)
Income taxes	$ 96,032	$ 80,256	$ 104,851

Reconciliation Between Income T

Reconciliation Between Income Tax Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Computed statutory tax expense		$ 65,781	$ 121,708	$ 127,176
Foreign inflation adjustments				(281)
State and local income taxes, net of federal income tax impact		12,686	12,857	12,081
Foreign losses not benefited and changes in valuation allowance		822	249	(34,757)
Foreign tax rate differential		2,235	(245)	(942)
Foreign dividends			13,662	68,684
Foreign tax credits		3,927	(21,647)	(62,815)
Impacts related to 2017 Tax Act	[1],[2]	19,180	(44,889)
Changes in uncertain tax positions		(6,139)	983	921
Other — net		(2,460)	(2,422)	(5,216)
Income taxes		$ 96,032	$ 80,256	$ 104,851
[1]	The year ended December 31, 2017 includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.
[2]	The year ended December 31, 2018 includes a one-time true-up of deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267.

Reconciliation Between Income_2

Reconciliation Between Income Tax Expenses (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
One-time benefit due to re-measurement of net deferred tax liabilities		$ (79,834)
One-time charge to true-up deferred taxes	$ 1,913
Deemed repatriation tax amount		14,512
Reduction in deferred tax assets with regard to foreign tax credit carryforwards	$ 17,267	$ 20,433

Net Long-Term Deferred Income T

Net Long-Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	$ 158,797	$ 147,208
Intangible asset — other	33,561	30,770
Intangible asset — tradenames	73,261	72,967
Investment in partnerships	63,217	67,449
Total deferred liabilities	328,836	318,394
Deferred lease expenses	13,464	14,714
Exchange loss	1,306	220
Deferred revenue - NCM	70,688	85,816
Capital lease obligations	63,895	67,369
Tax impact of items in accumulated other comprehensive income	2,237
Other tax loss carryforwards	15,608	15,564
Other tax credit carryforwards	42,989	38,436
Other expenses, not currently deductible for tax purposes	26,776	13,801
Total deferred assets	236,963	235,920
Net deferred income tax liability before valuation allowance	91,873	82,474
Valuation allowance against deferred assets – non-current	54,725	35,246
Net deferred income tax liability	146,598	117,720
Foreign
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability		3,073
Net deferred income tax (asset)	(5,449)
U.S.
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	$ 152,047	$ 114,647

Reconciliation of Total Amounts

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Beginning Balance	$ 18,266	$ 17,403	$ 17,133
Gross increases - tax positions in prior periods		92	13
Gross decreases - tax positions in prior periods	(143)	(12)
Gross increases - current period tax positions	424	265	923
Settlements	(7,191)	(177)	(924)
Foreign currency translation adjustments	(795)	695	258
Ending Balance	$ 10,561	$ 18,266	$ 17,403

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Commitments and Contingencies Disclosure [Line Items]
Liability for deferred lease expenses	$ 39,235	$ 40,929
Employer matching contribution payments	5,076	$ 6,380
Liability recorded for employer contribution payments	$ 1,374
Other Employees Except Tim Warner
Commitments and Contingencies Disclosure [Line Items]
Employment agreements term extension	1 year
Robert Carmony
Commitments and Contingencies Disclosure [Line Items]
Employment agreement termination date	Jan. 2, 2018
Zoradi
Commitments and Contingencies Disclosure [Line Items]
Extended term date of employment agreement	Dec. 31, 2019
Minimum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	10 years
Maximum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	25 years

Rent Expenses (Detail)

Rent Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Commitments And Contingencies Disclosure [Abstract]
Fixed rent expense	$ 248,543	$ 247,908	$ 242,927
Contingent rent and other facility lease expenses	74,773	80,289	78,367
Total facility lease expense	$ 323,316	$ 328,197	$ 321,294

Future Minimum Lease Payments u

Future Minimum Lease Payments under Noncancelable Operating and Capital Leases Remaining Terms in Excess of One Year (Detail) - USD ($) $ in Thousands		Dec. 31, 2018		Dec. 31, 2017
Commitments And Contingencies Disclosure [Abstract]
Future minimum operating lease payments, current	[1]	$ 253,323
Future minimum operating lease payments, in two years	[1]	242,336
Future minimum operating lease payments, in three years	[1]	230,396
Future minimum operating lease payments, in four years	[1]	204,628
Future minimum operating lease payments, in five years	[1]	176,802
Future minimum operating lease payments, thereafter	[1]	677,091
Future minimum operating lease payments, total	[1]	1,784,576
Future minimum capital leases payments, current	[1]	42,434
Future minimum capital leases payments, in two years	[1]	41,502
Future minimum capital leases payments, in three years	[1]	34,589
Future minimum capital leases payments, in four years	[1]	32,462
Future minimum capital leases payments, in five years	[1]	28,534
Future minimum capital leases payments, thereafter	[1]	166,375
Future minimum capital leases payments, total	[1]	345,896
Amounts representing interest payments	[1]	(86,364)
Present value of future minimum payments	[1]	259,532
Current portion of capital lease obligations		(27,065)	[1]	$ (25,511)
Capital lease obligations, less current portion		$ 232,467	[1]	$ 251,151
[1]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Revenues		$ 3,221,735	$ 2,991,547	$ 2,918,765
Adjusted EBITDA		783,130	725,269	707,840
Capital expenditures		346,073	380,862	326,908
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[1]	2,538,957
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		682,778
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		2,551,719	2,236,237	2,230,693
Adjusted EBITDA		650,189	559,693	550,150
Capital expenditures		270,870	321,040	242,271
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		682,778	769,436	701,573
Adjusted EBITDA		132,941	165,576	157,690
Capital expenditures		75,203	59,822	84,637
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (12,762)	$ (14,126)	$ (13,501)
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 17 for additional information on intercompany eliminations.

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		Mar. 29, 2018	[2]	Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting [Abstract]
Net income												$ 217,213	$ 267,482	$ 258,513
Add (deduct):
Income taxes												96,032	80,256	104,851
Interest expense	[1]											109,994	105,918	108,313
Loss on debt amendments and refinancing		$ 1,484		$ 331		$ 190		$ 161		$ 249		1,484	521	13,445
Other income	[3]											(18,450)	(43,121)	(44,813)
Other cash distributions from equity investees	[4]											30,143	25,973	21,916
Depreciation and amortization												261,162	237,513	209,071
Impairment of long-lived assets												32,372	15,084	2,836
Loss on disposal of assets and other												38,702	22,812	20,459
Deferred lease expenses												(1,320)	(1,268)	(990)
Amortization of long-term prepaid rents												2,382	2,274	1,826
Share based awards compensation expense												13,416	11,825	12,413
Adjusted EBITDA												$ 783,130	$ 725,269	$ 707,840
[1]	Includes amortization of debt issue costs.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.
[3]	Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM.
[4]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 3,221,735	$ 2,991,547	$ 2,918,765
Theatre Properties and Equipment - net	1,833,133	1,828,054
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	2,551,719	2,236,237	2,230,693
Theatre Properties and Equipment - net	1,479,603	1,439,168
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	283,009	341,485	304,407
Theatre Properties and Equipment - net	140,570	179,669
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	399,769	427,951	397,166
Theatre Properties and Equipment - net	212,960	209,217
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (12,762)	$ (14,126)	$ (13,501)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2018USD ($)TheatreFacilityLease	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Related Party Transaction [Line Items]
Cash dividends paid to Cinemark Holdings, Inc.	$ 148,750,000	$ 134,500,000	$ 124,900,000
Receivable from Cinemark Holdings, Inc.	$ 19,530,000	14,581,000
FE Concepts LLC
Related Party Transaction [Line Items]
Equity method investment, ownership percentage	50.00%
Laredo Theatres, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	654,000	586,000	506,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	68,000	131,000	110,000
Pinstack
Related Party Transaction [Line Items]
Amount paid for the event for employees and their families	$ 5,000	36,000	70,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 23,447,000	22,483,000	21,124,000
Cinemark Holdings, Inc.
Related Party Transaction [Line Items]
Cash dividends paid to Cinemark Holdings, Inc.	148,750,000	134,500,000	$ 124,900,000
Receivable from Cinemark Holdings, Inc.	$ 19,530,000	$ 14,581,000

Valuation Allowance of Deferred

Valuation Allowance of Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 35,246		$ 14,524	$ 50,636
Additions	22,005	[1]	21,347	483
Deductions	(2,526)		(625)	(36,595)
Ending Balance	$ 54,725		$ 35,246	$ 14,524
[1]	A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Dec. 31, 2018USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 426,216		$ 522,415
Other current assets	132,797		135,021
Accounts receivable from parent or subsidiaries	19,530		14,581
Total current assets	578,543		672,017
Theatre properties and equipment - net	1,833,133		1,828,054
Investment in subsidiaries	0		0
Other assets	2,089,675		1,985,269
Total assets	4,501,351		4,485,340
Current liabilities
Current portion of long-term debt	7,984		7,099
Current portion of capital lease obligations	27,065	[1]	25,511
Accounts payable and accrued expenses	439,004		435,676
Accounts payable to parent or subsidiaries	0		0
Total current liabilities	474,053		468,286
Long-term liabilities
Long-term debt, less current portion	1,772,627		1,780,381
Capital lease obligations, less current portion	232,467	[1]	251,151
Other long-term liabilities and deferrals	545,021		564,027
Total long-term liabilities	2,550,115		2,595,559
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543		49,543
Other stockholder's equity	1,415,261		1,360,059
Total Cinemark USA, Inc.'s stockholder's equity	1,464,804		1,409,602
Noncontrolling interests	12,379		11,893
Total equity	1,477,183		1,421,495	$ 1,284,080	$ 1,113,251
Total liabilities and equity	4,501,351		4,485,340
Eliminations
Current assets
Cash and cash equivalents	0		0
Other current assets	(15,178)		(19,270)
Accounts receivable from parent or subsidiaries	(265,363)		(223,007)
Total current assets	(280,541)		(242,277)
Theatre properties and equipment - net	0		0
Investment in subsidiaries	(1,864,100)		(1,813,421)
Other assets	(112,536)		(113,720)
Total assets	(2,257,177)		(2,169,418)
Current liabilities
Current portion of long-term debt	0		0
Current portion of capital lease obligations	0		0
Accounts payable and accrued expenses	(13,622)		(6,402)
Accounts payable to parent or subsidiaries	(265,363)		(223,007)
Total current liabilities	(278,985)		(229,409)
Long-term liabilities
Long-term debt, less current portion	(107,955)		(109,822)
Capital lease obligations, less current portion	0		0
Other long-term liabilities and deferrals	(6,137)		(16,766)
Total long-term liabilities	(114,092)		(126,588)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	(467,606)		(467,606)
Other stockholder's equity	(1,396,494)		(1,345,815)
Total Cinemark USA, Inc.'s stockholder's equity	(1,864,100)		(1,813,421)
Noncontrolling interests	0		0
Total equity	(1,864,100)		(1,813,421)
Total liabilities and equity	(2,257,177)		(2,169,418)
Cinemark USA, Inc.
Current assets
Cash and cash equivalents	197,965		130,590
Other current assets	60,829		59,661
Accounts receivable from parent or subsidiaries	0		117,972
Total current assets	258,794		308,223
Theatre properties and equipment - net	664,759		650,783
Investment in subsidiaries	1,806,255		1,691,626
Other assets	1,500,366		1,427,328
Total assets	4,230,174		4,077,960
Current liabilities
Current portion of long-term debt	6,595		5,710
Current portion of capital lease obligations	11,918		9,532
Accounts payable and accrued expenses	297,302		215,580
Accounts payable to parent or subsidiaries	40,421		0
Total current liabilities	356,236		230,822
Long-term liabilities
Long-term debt, less current portion	1,872,627		1,878,992
Capital lease obligations, less current portion	123,329		132,189
Other long-term liabilities and deferrals	413,177		426,355
Total long-term liabilities	2,409,133		2,437,536
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543		49,543
Other stockholder's equity	1,415,262		1,360,059
Total Cinemark USA, Inc.'s stockholder's equity	1,464,805		1,409,602
Noncontrolling interests	0		0
Total equity	1,464,805		1,409,602
Total liabilities and equity	4,230,174		4,077,960
Subsidiary Guarantors
Current assets
Cash and cash equivalents	10,886		180,623
Other current assets	19,997		17,841
Accounts receivable from parent or subsidiaries	284,893		119,616
Total current assets	315,776		318,080
Theatre properties and equipment - net	789,536		765,500
Investment in subsidiaries	57,845		121,795
Other assets	155,011		134,845
Total assets	1,318,168		1,340,220
Current liabilities
Current portion of long-term debt	0		0
Current portion of capital lease obligations	9,406		11,124
Accounts payable and accrued expenses	58,544		116,409
Accounts payable to parent or subsidiaries	0		0
Total current liabilities	67,950		127,533
Long-term liabilities
Long-term debt, less current portion	0		0
Capital lease obligations, less current portion	59,539		75,767
Other long-term liabilities and deferrals	60,137		60,567
Total long-term liabilities	119,676		136,334
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	457,368		457,368
Other stockholder's equity	673,174		618,985
Total Cinemark USA, Inc.'s stockholder's equity	1,130,542		1,076,353
Noncontrolling interests	0		0
Total equity	1,130,542		1,076,353
Total liabilities and equity	1,318,168		1,340,220
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	217,365		211,202
Other current assets	67,149		76,789
Accounts receivable from parent or subsidiaries	0		0
Total current assets	284,514		287,991
Theatre properties and equipment - net	378,838		411,771
Investment in subsidiaries	0		0
Other assets	546,834		536,816
Total assets	1,210,186		1,236,578
Current liabilities
Current portion of long-term debt	1,389		1,389
Current portion of capital lease obligations	5,741		4,855
Accounts payable and accrued expenses	96,780		110,089
Accounts payable to parent or subsidiaries	224,942		223,007
Total current liabilities	328,852		339,340
Long-term liabilities
Long-term debt, less current portion	7,955		11,211
Capital lease obligations, less current portion	49,599		43,195
Other long-term liabilities and deferrals	77,844		93,871
Total long-term liabilities	135,398		148,277
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	10,238		10,238
Other stockholder's equity	723,319		726,830
Total Cinemark USA, Inc.'s stockholder's equity	733,557		737,068
Noncontrolling interests	12,379		11,893
Total equity	745,936		748,961
Total liabilities and equity	$ 1,210,186		$ 1,236,578
[1]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		Mar. 29, 2018	[2]	Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Revenues												$ 3,221,735	$ 2,991,547	$ 2,918,765
Cost of operations
Theatre operating expenses												2,335,975	2,170,578	2,120,109
General and administrative expenses												162,640	150,911	140,637
Depreciation and amortization												261,162	237,513	209,071
Impairment of long-lived assets												32,372	15,084	2,836
Loss on disposal of assets and other												38,702	22,812	20,459
Total cost of operations												2,830,851	2,596,898	2,493,112
Operating income												390,884	394,649	425,653
Other income (expense)
Interest expense	[1]											(109,994)	(105,918)	(108,313)
Loss on debt amendments and refinancing		$ (1,484)		$ (331)		$ (190)		$ (161)		$ (249)		(1,484)	(521)	(13,445)
Equity in income of affiliates												39,242	35,985	31,962
Other income												(1,068)	7,136	12,851
Total other expense												(77,639)	(46,911)	(62,289)
Income before income taxes												313,245	347,738	363,364
Income taxes												96,032	80,256	104,851
Net income												217,213	267,482	258,513
Less: Net income attributable to noncontrolling interests												1,478	1,839	1,736
Net income attributable to Cinemark USA, Inc.												215,735	265,643	256,777
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenues												(56,590)	(50,756)	(53,147)
Cost of operations
Theatre operating expenses												(56,590)	(50,756)	(53,147)
General and administrative expenses												0	0	0
Depreciation and amortization												0	0	0
Impairment of long-lived assets												0	0	0
Loss on disposal of assets and other												0	0	0
Total cost of operations												(56,590)	(50,756)	(53,147)
Operating income												0	0	0
Other income (expense)
Interest expense												1,377	1,433	1,309
Loss on debt amendments and refinancing												0	0	0
Equity in income of affiliates												(164,827)	(270,189)	(301,946)
Other income												(1,377)	(1,433)	(1,309)
Total other expense												(164,827)	(270,189)	(301,946)
Income before income taxes												(164,827)	(270,189)	(301,946)
Income taxes												0	0	0
Net income												(164,827)	(270,189)	(301,946)
Less: Net income attributable to noncontrolling interests												0	0	0
Net income attributable to Cinemark USA, Inc.												(164,827)	(270,189)	(301,946)
NCM
Other income (expense)
Distributions from NCM												15,389	16,407	14,656
Interest expense - NCM												(19,724)
NCM | Eliminations
Other income (expense)
Distributions from NCM												0	0	0
Interest expense - NCM												0
Cinemark USA, Inc.
Condensed Financial Statements, Captions [Line Items]
Revenues												1,192,478	1,013,960	1,014,713
Cost of operations
Theatre operating expenses												916,726	795,976	804,041
General and administrative expenses												11,497	13,176	13,085
Depreciation and amortization												89,429	79,676	70,654
Impairment of long-lived assets												4,118	3,725	1,929
Loss on disposal of assets and other												13,321	16,895	5,613
Total cost of operations												1,035,091	909,448	895,322
Operating income												157,387	104,512	119,391
Other income (expense)
Interest expense												(97,585)	(94,229)	(96,442)
Loss on debt amendments and refinancing												(1,484)	(521)	(13,445)
Equity in income of affiliates												183,463	255,594	245,010
Other income												4,287	2,475	351
Total other expense												68,957	163,319	136,888
Income before income taxes												226,344	267,831	256,279
Income taxes												10,608	2,188	(498)
Net income												215,736	265,643	256,777
Less: Net income attributable to noncontrolling interests												0	0	0
Net income attributable to Cinemark USA, Inc.												215,736	265,643	256,777
Cinemark USA, Inc. | NCM
Other income (expense)
Distributions from NCM												0	0	1,414
Interest expense - NCM												(19,724)
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues												1,362,043	1,220,993	1,219,218
Cost of operations
Theatre operating expenses												933,858	834,135	828,905
General and administrative expenses												100,407	82,955	84,453
Depreciation and amortization												99,627	87,463	79,139
Impairment of long-lived assets												13,612	1,502	0
Loss on disposal of assets and other												23,337	3,372	13,759
Total cost of operations												1,170,841	1,009,427	1,006,256
Operating income												191,202	211,566	212,962
Other income (expense)
Interest expense												(6,520)	(7,675)	(7,538)
Loss on debt amendments and refinancing												0	0	0
Equity in income of affiliates												(12,561)	16,838	58,528
Other income												(14)	1,040	19
Total other expense												(19,095)	10,203	51,009
Income before income taxes												172,107	221,769	263,971
Income taxes												68,624	69,770	52,277
Net income												103,483	151,999	211,694
Less: Net income attributable to noncontrolling interests												0	0	0
Net income attributable to Cinemark USA, Inc.												103,483	151,999	211,694
Subsidiary Guarantors | NCM
Other income (expense)
Distributions from NCM												0	0	0
Interest expense - NCM												0
Subsidiary Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues												723,804	807,350	737,981
Cost of operations
Theatre operating expenses												541,981	591,223	540,310
General and administrative expenses												50,736	54,780	43,099
Depreciation and amortization												72,106	70,374	59,278
Impairment of long-lived assets												14,642	9,857	907
Loss on disposal of assets and other												2,044	2,545	1,087
Total cost of operations												681,509	728,779	644,681
Operating income												42,295	78,571	93,300
Other income (expense)
Interest expense												(7,266)	(5,447)	(5,642)
Loss on debt amendments and refinancing												0	0	0
Equity in income of affiliates												33,167	33,742	30,370
Other income												(3,964)	5,054	13,790
Total other expense												37,326	49,756	51,760
Income before income taxes												79,621	128,327	145,060
Income taxes												16,800	8,298	53,072
Net income												62,821	120,029	91,988
Less: Net income attributable to noncontrolling interests												1,478	1,839	1,736
Net income attributable to Cinemark USA, Inc.												61,343	118,190	90,252
Subsidiary Non-Guarantors | NCM
Other income (expense)
Distributions from NCM												15,389	$ 16,407	$ 13,242
Interest expense - NCM												$ 0
[1]	Includes amortization of debt issue costs.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Condensed Consolidating State_2

Condensed Consolidating Statement of Comprehensive Income Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Statement Of Income Captions [Line Items]
Net income	$ 217,213	$ 267,482	$ 258,513
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	(3,851)	0	234
Other comprehensive income (loss) in equity method investments	(139)	248	89
Foreign currency translation adjustments	(62,253)	(4,966)	26,394
Total other comprehensive income (loss), net of tax	(66,243)	(4,718)	26,717
Total comprehensive income, net of tax	150,970	262,764	285,230
Comprehensive income attributable to noncontrolling interests	(1,478)	(1,839)	(1,769)
Comprehensive income attributable to Cinemark USA, Inc.	149,492	260,925	283,461
Eliminations
Condensed Statement Of Income Captions [Line Items]
Net income	(164,827)	(270,189)	(301,946)
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	0		0
Other comprehensive income (loss) in equity method investments	139	(248)	(89)
Foreign currency translation adjustments	62,253	4,966	(26,361)
Total other comprehensive income (loss), net of tax	62,392	4,718	(26,450)
Total comprehensive income, net of tax	(102,435)	(265,471)	(328,396)
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	(102,435)	(265,471)	(328,396)
Cinemark USA, Inc.
Condensed Statement Of Income Captions [Line Items]
Net income	215,736	265,643	256,777
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	(3,851)		234
Other comprehensive income (loss) in equity method investments	(139)	248	89
Foreign currency translation adjustments	(62,253)	(4,966)	26,361
Total other comprehensive income (loss), net of tax	(66,243)	(4,718)	26,684
Total comprehensive income, net of tax	149,493	260,925	283,461
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	149,493	260,925	283,461
Subsidiary Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	103,483	151,999	211,694
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	0		0
Other comprehensive income (loss) in equity method investments	0	0	0
Foreign currency translation adjustments	0	0	0
Total other comprehensive income (loss), net of tax	0	0	0
Total comprehensive income, net of tax	103,483	151,999	211,694
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	103,483	151,999	211,694
Subsidiary Non-Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	62,821	120,029	91,988
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	0		0
Other comprehensive income (loss) in equity method investments	(139)	248	89
Foreign currency translation adjustments	(62,253)	(4,966)	26,394
Total other comprehensive income (loss), net of tax	(62,392)	(4,718)	26,483
Total comprehensive income, net of tax	429	115,311	118,471
Comprehensive income attributable to noncontrolling interests	(1,478)	(1,839)	(1,769)
Comprehensive income attributable to Cinemark USA, Inc.	$ (1,049)	$ 113,472	$ 116,702

Condensed Consolidating State_3

Condensed Consolidating Statement of Comprehensive Income Information (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Information Of Subsidiaries Disclosure [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,243	$ 0	$ 138

Condensed Consolidating State_4

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities
Net income	$ 217,213	$ 267,482	$ 258,513
Adjustments to reconcile net income to cash provided by operating activities	346,659	252,168	232,308
Changes in assets and liabilities	(7,573)	8,734	(28,562)
Net cash provided by operating activities	556,299	528,384	462,259
Investing activities
Additions to theatre properties and equipment	(346,073)	(380,862)	(326,908)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(11,289)	(40,997)	(15,300)
Acquisition of screen advertising business			(1,450)
Proceeds from sale of theatre properties and equipment and other	3,920	15,098	3,570
Proceeds from intercompany note repayments	0
Proceeds from sale of marketable securities			13,451
Intercompany note issuances			0
Dividends received from subsidiaries		0	0
Investment in joint ventures and other	(19,535)	(3,715)	(1,132)
Net cash used for investing activities	(451,370)	(410,476)	(327,769)
Financing activities
Dividends paid to parent	(148,750)	(134,500)	(124,900)
Proceeds from issuance of Senior Notes, net of discount			222,750
Retirement of Senior Subordinated Notes			(200,000)
Repayments of long-term debt	(7,984)	(5,671)	(16,605)
Payment of debt issue costs	(5,218)	(1,146)	(7,217)
Fees paid related to debt amendments	(704)	(521)	(11,076)
Intercompany loan proceeds			0
Payments on capital leases	(25,353)	(21,725)	(19,343)
Proceeds from financing lease		10,200
Payments on intercompany loans	0
Other	(4,601)	(5,212)	(6,730)
Net cash used for financing activities	(191,906)	(157,429)	(163,121)
Effect of exchange rate changes on cash and cash equivalents	(9,222)	798	1,266
Increase (decrease) in cash and cash equivalents	(96,199)	(38,723)	(27,365)
Cash and cash equivalents:
Beginning of period	522,415	561,138	588,503
End of period	426,216	522,415	561,138
Eliminations
Operating activities
Net income	(164,827)	(270,189)	(301,946)
Adjustments to reconcile net income to cash provided by operating activities	164,827	270,189	301,946
Changes in assets and liabilities	0	0	0
Net cash provided by operating activities	0	0	0
Investing activities
Additions to theatre properties and equipment	0	0	0
Acquisition of theatres in the U.S. and international markets, net of cash acquired	0	0	0
Acquisition of screen advertising business			0
Proceeds from sale of theatre properties and equipment and other	0	0	0
Proceeds from intercompany note repayments	(1,867)
Proceeds from sale of marketable securities			0
Intercompany note issuances			4,455
Dividends received from subsidiaries		(129,473)	(255,682)
Investment in joint ventures and other	0	0	0
Net cash used for investing activities	(1,867)	(129,473)	(251,227)
Financing activities
Dividends paid to parent	0	129,473	255,682
Proceeds from issuance of Senior Notes, net of discount			0
Retirement of Senior Subordinated Notes			0
Repayments of long-term debt	0	0	0
Payment of debt issue costs	0		0
Fees paid related to debt amendments		0	0
Intercompany loan proceeds			(4,455)
Payments on capital leases	0	0	0
Proceeds from financing lease		0
Payments on intercompany loans	1,867
Other	0	0	0
Net cash used for financing activities	1,867	129,473	251,227
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents:
Beginning of period	0	0	0
End of period	0	0	0
NCM
Investing activities
Acquisition of NCM common units	(78,393)
NCM | Eliminations
Investing activities
Acquisition of NCM common units	0
Cinemark USA, Inc.
Operating activities
Net income	215,736	265,643	256,777
Adjustments to reconcile net income to cash provided by operating activities	(36,894)	(122,559)	(178,147)
Changes in assets and liabilities	229,325	18,223	154,085
Net cash provided by operating activities	408,167	161,307	232,715
Investing activities
Additions to theatre properties and equipment	(91,244)	(146,385)	(108,439)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	0	(12,500)	(15,300)
Acquisition of screen advertising business			0
Proceeds from sale of theatre properties and equipment and other	1,244	2,149	2,912
Proceeds from intercompany note repayments	1,867
Proceeds from sale of marketable securities			13,451
Intercompany note issuances			(4,455)
Dividends received from subsidiaries		127,600	26,033
Investment in joint ventures and other	0	0	(1,000)
Net cash used for investing activities	(166,526)	(29,136)	(86,798)
Financing activities
Dividends paid to parent	(148,750)	(134,500)	(124,900)
Proceeds from issuance of Senior Notes, net of discount			222,750
Retirement of Senior Subordinated Notes			(200,000)
Repayments of long-term debt	(7,984)	(4,282)	(15,201)
Payment of debt issue costs	(5,218)		(7,217)
Fees paid related to debt amendments		(521)	(11,076)
Intercompany loan proceeds			0
Payments on capital leases	(11,610)	(7,952)	(6,645)
Proceeds from financing lease		0
Payments on intercompany loans	0
Other	(704)	(1,181)	1,863
Net cash used for financing activities	(174,266)	(148,436)	(140,426)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	67,375	(16,265)	5,491
Cash and cash equivalents:
Beginning of period	130,590	146,855	141,364
End of period	197,965	130,590	146,855
Cinemark USA, Inc. | NCM
Investing activities
Acquisition of NCM common units	(78,393)
Subsidiary Guarantors
Operating activities
Net income	103,483	151,999	211,694
Adjustments to reconcile net income to cash provided by operating activities	162,811	71,023	55,128
Changes in assets and liabilities	(233,263)	(35,138)	(164,005)
Net cash provided by operating activities	33,031	187,884	102,817
Investing activities
Additions to theatre properties and equipment	(173,042)	(172,874)	(130,843)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	0	0	0
Acquisition of screen advertising business			0
Proceeds from sale of theatre properties and equipment and other	2,025	12,271	374
Proceeds from intercompany note repayments	0
Proceeds from sale of marketable securities			0
Intercompany note issuances			0
Dividends received from subsidiaries		1,873	229,649
Investment in joint ventures and other	(19,896)	(104)	0
Net cash used for investing activities	(190,913)	(158,834)	99,180
Financing activities
Dividends paid to parent	0	(127,000)	0
Proceeds from issuance of Senior Notes, net of discount			0
Retirement of Senior Subordinated Notes			0
Repayments of long-term debt	0	0	0
Payment of debt issue costs	0		0
Fees paid related to debt amendments		0	0
Intercompany loan proceeds			0
Payments on capital leases	(8,950)	(9,707)	(10,005)
Proceeds from financing lease		10,200
Payments on intercompany loans	0
Other	(2,905)	(2,943)	(6,834)
Net cash used for financing activities	(11,855)	(129,450)	(16,839)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	(169,737)	(100,400)	185,158
Cash and cash equivalents:
Beginning of period	180,623	281,023	95,865
End of period	10,886	180,623	281,023
Subsidiary Guarantors | NCM
Investing activities
Acquisition of NCM common units	0
Subsidiary Non-Guarantors
Operating activities
Net income	62,821	120,029	91,988
Adjustments to reconcile net income to cash provided by operating activities	55,915	33,515	53,381
Changes in assets and liabilities	(3,635)	25,649	(18,642)
Net cash provided by operating activities	115,101	179,193	126,727
Investing activities
Additions to theatre properties and equipment	(81,787)	(61,603)	(87,626)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(11,289)	(28,497)	0
Acquisition of screen advertising business			(1,450)
Proceeds from sale of theatre properties and equipment and other	651	678	284
Proceeds from intercompany note repayments	0
Proceeds from sale of marketable securities			0
Intercompany note issuances			0
Dividends received from subsidiaries		0	0
Investment in joint ventures and other	361	(3,611)	(132)
Net cash used for investing activities	(92,064)	(93,033)	(88,924)
Financing activities
Dividends paid to parent	0	(2,473)	(255,682)
Proceeds from issuance of Senior Notes, net of discount			0
Retirement of Senior Subordinated Notes			0
Repayments of long-term debt	0	(1,389)	(1,404)
Payment of debt issue costs	0		0
Fees paid related to debt amendments		0	0
Intercompany loan proceeds			4,455
Payments on capital leases	(4,793)	(4,066)	(2,693)
Proceeds from financing lease		0
Payments on intercompany loans	(1,867)
Other	(992)	(1,088)	(1,759)
Net cash used for financing activities	(7,652)	(9,016)	(257,083)
Effect of exchange rate changes on cash and cash equivalents	(9,222)	798	1,266
Increase (decrease) in cash and cash equivalents	6,163	77,942	(218,014)
Cash and cash equivalents:
Beginning of period	211,202	133,260	351,274
End of period	217,365	$ 211,202	$ 133,260
Subsidiary Non-Guarantors | NCM
Investing activities
Acquisition of NCM common units	$ 0

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2018		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 426,216		$ 522,415
Other current assets	152,327
Total current assets	578,543		672,017
Theatre properties and equipment, net	1,833,133		1,828,054
Other assets	2,089,675		1,985,269
Total assets	4,501,351		4,485,340
Current liabilities
Current portion of long-term debt	7,984		7,099
Current portion of capital lease obligations	27,065	[1]	25,511
Accounts payable and accrued expenses	439,004
Total current liabilities	474,053		468,286
Long-term liabilities
Long-term debt, less current portion	1,772,627		1,780,381
Capital lease obligations, less current portion	232,467	[1]	251,151
Other long-term liabilities and deferrals	545,021		564,027
Total long-term liabilities	2,550,115		2,595,559
Commitments and contingencies
Equity	1,477,183		1,421,495	$ 1,284,080	$ 1,113,251
Total liabilities and equity	4,501,351		$ 4,485,340
Restricted Subsidiaries
Current assets
Cash and cash equivalents	370,460
Other current assets	267,077
Total current assets	637,537
Theatre properties and equipment, net	1,833,133
Other assets	1,916,169
Total assets	4,386,839
Current liabilities
Current portion of long-term debt	6,595
Current portion of capital lease obligations	27,065
Accounts payable and accrued expenses	447,610
Total current liabilities	481,270
Long-term liabilities
Long-term debt, less current portion	2,014,327
Capital lease obligations, less current portion	232,467
Other long-term liabilities and deferrals	484,528
Total long-term liabilities	2,731,322
Commitments and contingencies
Equity	1,174,247
Total liabilities and equity	4,386,839
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents	55,756
Other current assets	(106,143)
Total current assets	(50,387)
Other assets	522,225
Total assets	471,838
Current liabilities
Current portion of long-term debt	1,389
Accounts payable and accrued expenses	1
Total current liabilities	1,390
Long-term liabilities
Other long-term liabilities and deferrals	60,493
Total long-term liabilities	60,493
Commitments and contingencies
Equity	409,955
Total liabilities and equity	471,838
Eliminations
Current assets
Other current assets	(8,607)
Total current assets	(8,607)
Other assets	(348,719)
Total assets	(357,326)
Current liabilities
Accounts payable and accrued expenses	(8,607)
Total current liabilities	(8,607)
Long-term liabilities
Long-term debt, less current portion	(241,700)
Total long-term liabilities	(241,700)
Commitments and contingencies
Equity	(107,019)
Total liabilities and equity	$ (357,326)
[1]	Represents amounts before the adoption of ASC Topic 842 – Leases. See Note 2 for discussion of the expected impact of adoption.

Supplemental Schedules - Cond_2

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 3,221,735	$ 2,991,547	$ 2,918,765
Cost of operations
Theatre operating costs	2,335,975	2,170,578	2,120,109
General and administrative expenses	162,640
Depreciation and amortization	261,162	237,513	209,071
Impairment of long-lived assets	32,372
Loss on sale of assets and other	38,702	22,812	20,459
Total cost of operations	2,830,851	2,596,898	2,493,112
Operating income	390,884	394,649	425,653
Other income (expense)	(77,639)	(46,911)	(62,289)
Income before income taxes	313,245	347,738	363,364
Income taxes	96,032	80,256	104,851
Net income	217,213	267,482	258,513
Less: Net income attributable to noncontrolling interests	1,478	1,839	1,736
Net income attributable to Cinemark USA, Inc.	215,735	$ 265,643	$ 256,777
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues	3,221,735
Cost of operations
Theatre operating costs	2,335,975
General and administrative expenses	162,645
Depreciation and amortization	261,162
Impairment of long-lived assets	32,372
Loss on sale of assets and other	38,702
Total cost of operations	2,830,856
Operating income	390,879
Other income (expense)	(154,545)
Income before income taxes	236,334
Income taxes	72,086
Net income	164,248
Less: Net income attributable to noncontrolling interests	1,478
Net income attributable to Cinemark USA, Inc.	162,770
Unrestricted
Cost of operations
General and administrative expenses	(5)
Total cost of operations	(5)
Operating income	5
Other income (expense)	76,906
Income before income taxes	76,911
Income taxes	23,946
Net income	52,965
Net income attributable to Cinemark USA, Inc.	$ 52,965

Supplemental Schedules - Cond_3

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net income	$ 217,213	$ 267,482	$ 258,513
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $138, $0 and $1,243, net of settlements	(3,851)	0	234
Other comprehensive loss in equity method investments	(139)	248	89
Foreign currency translation adjustments	(62,253)
Total other comprehensive income (loss), net of tax	(66,243)	(4,718)	26,717
Total comprehensive income, net of tax	150,970	262,764	285,230
Comprehensive income attributable to noncontrolling interests	(1,478)	(1,839)	(1,769)
Comprehensive income attributable to Cinemark USA, Inc.	149,492	$ 260,925	$ 283,461
Restricted Subsidiaries
Net income	164,248
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $138, $0 and $1,243, net of settlements	(3,851)
Foreign currency translation adjustments	(62,253)
Total other comprehensive income (loss), net of tax	(66,104)
Total comprehensive income, net of tax	98,144
Comprehensive income attributable to noncontrolling interests	(1,478)
Comprehensive income attributable to Cinemark USA, Inc.	96,666
Unrestricted Subsidiaries
Net income	52,965
Other comprehensive income (loss), net of tax
Other comprehensive loss in equity method investments	(139)
Total other comprehensive income (loss), net of tax	(139)
Total comprehensive income, net of tax	52,826
Comprehensive income attributable to Cinemark USA, Inc.	$ 52,826

Supplemental Schedules - Cond_4

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 1,243	$ 0	$ 138

Supplemental Schedules - Cond_5

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities
Net income	$ 217,213	$ 267,482	$ 258,513
Adjustments to reconcile net income to cash provided by operating activities	346,659	252,168	232,308
Changes in assets and liabilities	(7,573)	8,734	(28,562)
Net cash provided by operating activities	556,299	528,384	462,259
Investing activities
Additions to theatre properties and equipment and other	(346,073)	(380,862)	(326,908)
Proceeds from sale of theatre properties and equipment and other	3,920	15,098	3,570
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(11,289)	(40,997)	(15,300)
Investment in joint ventures and other	(19,535)	(3,715)	(1,132)
Net cash used for investing activities	(451,370)	(410,476)	(327,769)
Financing activities
Dividends paid to parent	(148,750)	(134,500)	(124,900)
Repayments on long-term debt	(7,984)	(5,671)	(16,605)
Payment of debt issue costs	(5,218)	(1,146)	(7,217)
Payments on capital leases	(25,353)	(21,725)	(19,343)
Other	(4,601)
Net cash used for financing activities	(191,906)	(157,429)	(163,121)
Effect of exchange rate changes on cash and cash equivalents	(9,222)	798	1,266
Increase (decrease) in cash and cash equivalents	(96,199)	(38,723)	(27,365)
Cash and cash equivalents:
Beginning of period	522,415	561,138	588,503
End of period	426,216	522,415	$ 561,138
Restricted Subsidiaries
Operating activities
Net income	164,248
Adjustments to reconcile net income to cash provided by operating activities	343,793
Changes in assets and liabilities	32,060
Net cash provided by operating activities	540,101
Investing activities
Additions to theatre properties and equipment and other	(346,073)
Proceeds from sale of theatre properties and equipment and other	3,920
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(11,289)
Investment in joint ventures and other	(19,896)
Net cash used for investing activities	(451,731)
Financing activities
Dividends paid to parent	(148,750)
Borrowings from affiliate	21,700
Repayments on long-term debt	(7,984)
Payment of debt issue costs	(5,218)
Payments on capital leases	(25,353)
Other	(4,601)
Net cash used for financing activities	(170,206)
Effect of exchange rate changes on cash and cash equivalents	(9,222)
Increase (decrease) in cash and cash equivalents	(91,058)
Cash and cash equivalents:
Beginning of period	461,518
End of period	370,460	461,518
Unrestricted Subsidiaries
Operating activities
Net income	52,965
Adjustments to reconcile net income to cash provided by operating activities	2,866
Changes in assets and liabilities	(39,633)
Net cash provided by operating activities	16,198
Investing activities
Loans to affiliates	(21,700)
Investment in joint ventures and other	361
Net cash used for investing activities	(21,339)
Financing activities
Increase (decrease) in cash and cash equivalents	(5,141)
Cash and cash equivalents:
Beginning of period	60,897
End of period	55,756	$ 60,897
NCM
Investing activities
Acquisition of NCM common units	(78,393)
NCM | Restricted Subsidiaries
Investing activities
Acquisition of NCM common units	(78,393)
Eliminations
Investing activities
Loans to affiliates	21,700
Net cash used for investing activities	21,700
Financing activities
Borrowings from affiliate	(21,700)
Net cash used for financing activities	$ (21,700)